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ABSTRACT 
 
Coevolution between microbes and their viruses influences the trajectories of these 
communities through gene transfer and predation.  When these communities are a part of 
the human microbiome, these interactions can also have significant impacts on the health 
of the human host.  The CRISPR adaptive immune system is one of the ways in which 
microbes defend against viral infection, and it also holds a record of acquired immunity, 
allowing us to read a history of microbe-viral interactions.  In this work, we examine the 
emergence, impact, and applications of diverse CRISPR immune alleles in microbial 
populations.  Using a mathematical model of CRISPR-mediated host-virus coevolution to 
simulate microbial populations, we observe the emergence of multiple coexisting 
CRISPR alleles in a single population, which we call distributed immunity.  We find that 
distributed immunity is most likely to occur in communities with more potential spacers 
and relatively low viral mutation rates, and that it is linked to increased stability for the 
host population, while the viral population is driven to lower densities or even to 
extinction.  To see if this phenomenon is also present in natural microbial populations, we 
examined CRISPR diversity in two human-associated communities: the vaginal 
microbiomes of pregnant women and the lung microbiomes of cystic fibrosis patients.  
To investigate the vaginal microbiome, we developed a network-based methodology to 
identify and extract CRISPR spacers from all species present in samples taken from 
pregnant women at high and low risk of preterm birth.  This approach yielded over 20 
different CRISPR types, with spacer content varying among individuals. Coexisting 
alleles linked to shifts in the abundance of the matched element were detected in one 
Lactobacillus species in one of the samples, demonstrating the potential of our approach.  
In the cystic fibrosis lung microbiome, we used this method to identify CRISPRs in four 
patients infected with the major cystic fibrosis pathogen Pseudomonas aeruginosa. 
Spacer content was completely different between patients, but no variation was detected 
within a patient. Finally, we examined spacer diversity in a large global dataset of P. 
aeruginosa and used the thousands of spacers identified as a tracking tool to monitor 
dynamics of viral populations.  This approach, which we refer to as prototyping, revealed 
a panmictic P. aeruginosa phage population and holds promise as a tool for tracking 
mobile elements and personalizing phage therapy treatments. 
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CHAPTER 1 
Introduction1 
Microbe-virus coevolution shapes microbial communities of all types, including 
environmentally important systems from oceans to acid mine drainage [4,74,75] and 
medically relevant systems such as the gut microbiome [61,72].  Viruses can act as 
predators, imposing strong selective pressures on their hosts which shape their 
evolutionary trajectories.  When not lethal, viruses are also a source of new, potentially 
advantageous genes and a vector for moving genes among organisms.  When these 
microbial hosts are also pathogens to a human host, the importance of these viruses can 
be amplified as their effects on their microbial hosts in turn impact the trajectory of 
human disease.  Histories of microbe-virus interactions and patterns of immunity become 
critical for understanding how communities develop.   
CRISPRs: A Microbial Adaptive Immune System 
There are many antiviral defense mechanisms to be found in the microbial world [53]; 
one of the most fascinating is the CRISPR (clustered regularly interspaced short 
palindromic repeats) system.  This widespread system is present in the majority of all 
sequenced bacteria and archaea [49] and functions as an adaptive immune system for 
microbes which possess it.   The CRISPR system is comprised of two main components: 
arrays of the aforementioned short palindromic repeats interspersed with short DNA 
fragments known as spacers, and a number of CRISPR-associated (cas) genes which 
carry out the functions of the system.  CRISPR spacers often match the sequence of 
portions of foreign or mobile genetic elements such as viruses, plasmids, and transposons 
[63]; the matched portion is known as a protospacer.   New spacers can be sampled from 
genetic elements, possibly using double-strand breaks in DNA that occur during 
replication [55], and integrated at the leader end of the array [5].  This polar addition of 
new spacers enables usage of CRISPRs as a historical record of host-virus interactions. 
                                                          
1 Portions of this chapter were previously published as England, W.E. and Whitaker, R.J. (2013). 
Evolutionary causes and consequences of diversified CRISPR immune profiles in natural 
populations. Biochem. Soc. Trans. 41 (6), 1431–1436, and are reprinted here with permission. 
 
2 
 
While the genes responsible for spacer acquisition are conserved among the many types 
of CRISPRs present in microbes, the remaining cas genes vary widely between types, as 
does the implementation of immunity [58,59].  However; all known CRISPR systems 
follow the same essential protocol.  The repeat-spacer array is transcribed to pre-crRNA 
and then processed into smaller RNA fragments containing the sequence of a single 
spacer.  These crRNAs are used to target protospacer sequences in DNA, or in some 
cases RNA [33], and a nuclease is recruited to cleave and inactivate the targeted element 
[12].  To avoid fatal targeting of the host genome, some types of CRISPRs employ 
protospacer-adjacent motifs, or PAMs.  These short sequences are essential for targeting 
and are found next to protospacers, but are absent from the spacer-separating repeat 
sequences, preventing targeting of spacers in the host [64]. 
In response to the CRISPR threat, targeted elements can evade CRISPR immunity by 
acquiring random mutations in their protospacers so there is no longer a sufficient match 
between the spacer and the mutated protospacer [22,79], or through the use of anti-
CRISPR proteins present in some viruses, which inhibit CRISPR-cas binding or nuclease 
recruitment [10,11,67].  The ability for viruses and other elements to evade CRISPR 
immunity through simple mutation highlights the potential advantage of a host 
maintaining multiple spacers matching different protospacers in the same virus – a 
diverse immune repertoire could help prevent viral CRISPR escape. 
CRISPR Diversity and Evolution 
CRISPR immune profiles in natural microbial populations 
Polymorphism and rapid evolution of spacers between direct repeats within the bacterial 
and archaeal genomes was observed long before the mechanism and function of 
CRISPRs in adaptive immunity were recognized [48,62].  Polymorphism was assessed by 
looking at deletions of spacers between repeat sequences whose function for the cell was 
unknown [41].  For example, fingerprints of these repeated regions were used for typing 
of mycobacterial strains called spoligotyping (spacer oligonucleotide typing) [29] and to 
infer the structure of these pathogen populations [50].  Differences in diversity among 
populations were observed; for example, some mycobacterial outbreaks have a coexisting 
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diverse set of strains (polyclonal) and others have identical alleles (monoclonal) [50].  
The discovery that these repeat arrays within populations were specifically related to 
bacterial and archaeal immunity [5] transformed the significance of spoligotyping by 
directly relating diversity of repeat loci into variation in host immunity.   
Using PCR to amplify, sequence, and assemble CRISPR repeat-spacer alleles from 
isolated individuals or directly from environmental samples, several studies have recently 
investigated the diversity of CRISPRs within microbial populations.   These studies have 
revealed a spectrum of population structures ranging from monoclonal to highly 
polyclonal. E. coli isolates exhibit minimal variation; no new spacers are observed in 
strains which have diverged in the past 250,000 years, and most observed variation 
appears to be the result of spacer loss [81,82].   Similarly, Salmonella CRISPR loci show 
variation primarily due to spacer deletion, rather than acquisition of new spacers, and 
appear to be highly monoclonal [25,77].  Increasing in diversity, nearly clonal 
populations of Leptospirillum in acid mine drainage show extensive diversity at the 
leader end of the CRISPR array but identity at the trailer end [83].   Populations of 
Yersinia pestis, known for extremely low sequence diversity at other genomic loci [3], 
show nearly clonal trailer-end spacers with leader-end variation [20,73]. At the other 
extreme, Streptococcus thermophilus exhibits hypervariability in its CRISPR loci; 
diversity is concentrated at the leader end, but multiple trailer types also exist [43]. 
Completely distinct CRISPR repeat spacer alleles (at both the leader and the trailer end) 
have been shown to coexist within a single population of the archaeon Sulfolobus 
islandicus [39]. 39 isolates of S. islandicus from a single hot spring sample collected in 
the year 2000 maintain extensive leader-end diversity, but also contain 8-10 completely 
different trailer-end alleles at each of three loci at relatively even abundance [39].  A later 
study involving 120 S. islandicus strains taken from the same population ten years later 
found leader- and trailer-end diversity persisted through time [40]. Why do some 
microbial populations exhibit extensive CRISPR immune diversity while others do not?  
What does this difference in diversity between populations tell us about the ongoing 
coevolutionary dynamic in these populations? What effect does diversity in CRISPR 
immunity have on evolution of pathogen populations? 
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Forces that lead to monoclonality in CRISPR immunity 
Based on simple Lotka-Volterra [56] dynamics, coevolutionary models predict that at any 
one time and place a population of hosts would have a single dominant CRISPR allele.  
Ongoing arms races between viruses and microbial hosts lead to periodic oscillations in 
immune host genotypes and subsequent selection of viral evasion mutants that can 
subvert the CRISPR immune surveillance [8]. The prediction is that each oscillation is 
driven by a selective sweep of an effective immune allele to fixation within a population.  
If these dynamics are actively ongoing, this model for diversity predicts that different 
populations of the same archaea or bacteria would have different, monoclonal immune 
alleles, as they could be at different points in their coevolutionary trajectories.  Therefore, 
if population structure is not well understood, this same evolutionary dynamic could 
result in apparent diversity of a particular allele when compared among populations that 
are in fact isolated.   
Several other evolutionary, but not coevolutionary, forces could result in monoclonality 
at the CRISPR locus.  Other defense loci such as surface resistance could dominate the 
host-pathogen dynamic, resulting in clonal CRISPR alleles as the linked resistance locus 
is swept to fixation within the population.  Clonality at a CRISPR locus could also result 
from demographic history such as bottleneck that would reduce diversity to a single 
individual allele by chance. Since new CRISPR spacers are added to the leader end, 
monoclonality at the leader end of the locus has been suggested to result from loss of 
function of the acquisition machinery in a particular system or the CRISPR system in 
general within a population. 
Forces that lead to polyclonality in CRISPR immunity 
Three basic theoretical models of host-pathogen coevolution predict that polymorphism 
can be generated and maintained within populations [13].  In the first, explicit tradeoffs 
between resistance or immunity and fitness are required for diversity to emerge [89].  In 
experimental evolutionary models, such tradeoffs have been observed to promote the 
coexistence of multiple host or viral genotypes over time [9,14,15,54,86,89].  Associating 
a cost with CRISPR immunity, these models predict that the maintenance of a CRISPR 
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system is only adaptive if viral diversity is limited.  A second model to promote diversity 
is negative frequency-dependent selection, where the adaptive benefit of a novel allele 
decreases as it increases in frequency within a population [19,34,52,65].  In this model, 
diversity is maintained in microbial populations through negative frequency dependence 
without explicit tradeoffs between resistance alleles.  Finally, spatial structure within 
populations has been shown to promote diversity.  Spatial models have been applied to 
simulations based on CRISPR immunity to predict that they are essential to maintain 
diversity [30,31]. 
In applying these coevolutionary models to explain the CRISPR diversity, it is important 
to consider two crucial elements of the CRISPR system distinguish it in mechanism and 
model from previously described systems for host-pathogen coevolution.  First, the 
addition of new spacers to the CRISPR system is “Lamarkian” in that new genotypes are 
created upon a viral encounter and can be passed on to the next generation [51].  
Although the frequency at which new spacers are acquired by hosts has not been well 
defined, it is believed to be higher than the genome mutation rate, leading to the potential 
for competing mutations to exist within a population at one time [39].  Second, host cells 
are not subject to a large fitness drag as consequence of investment in new immune 
phenotypes.  The number of potential immune phenotypes for a population of infected 
cells is limited only by the number of protospacer sites within each virus, and each is 
likely to have equal fitness consequences to the host cell.  
One additional biological factor that has attracted less attention in terms of its impact on 
maintaining diversity in natural populations has been the effect of reassortment and 
recombination of CRISPR loci among individuals within a population.  This effect is not 
dependent upon the CRISPR mechanism of mutation and action, but has been shown to 
be important for any traits that are under strong selection such as those involve in 
resistance and immunity.  The Red Queen hypothesis [84] states that antagonistically 
coevolving organisms must continually adapt simply to survive against their ever-
changing antagonists. This hypothesis has been applied to explain the maintenance of 
sexual reproduction; sexual exchange of genetic information increases the creation of 
novel genotypes and consequently new immunity, resistance and virulence mechanisms 
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[7,35,46,68]. Similarly, recombination between organisms shuffles existing gene content, 
allowing for new, possibly advantageous combinations. Recombination is predicted to be 
especially beneficial when the population is under strong selection, as they are in traits 
involved in resistance and immunity [6,66]. In a microbial population coevolving with 
lytic viruses, the viral threat provides strong selection pressure for immunity or resistance 
in the microbial host. The immunity provided by the spacer of the CRISPR-Cas system 
makes it likely that horizontal transfer of repeat-spacer arrays and cas genes would occur 
in such populations. 
A recent study of a single natural S. islandicus population found evidence for rapid 
recombinatorial reassortment of entire CRISPR loci among strains [40]. Out of a set of 53 
natural S. islandicus isolates with CRISPR loci where leader-end spacers were observed 
multiple times, leader-end alleles were found linked to different trailer-end alleles in less 
than 1% of cases; only four examples of identical spacers shared between loci were 
identified. By contrast, linkage among the three CRISPR loci present in this population 
was found to be low, indicating that complete repeat-spacer arrays are reassorted 
throughout this population [40]. These findings are in line with observations from other 
studies outside of a single natural population. A comparison of natural E. coli isolates 
found that phylogenetically close strains typically have very similar spacers, but in some 
cases these strains harbor completely different spacer sets; in over half of cases where the 
spacers were completely different, the spacers match those of very distant strains, 
implicating horizontal transfer of spacer arrays [81]. A broad comparison of bacterial 16S 
rRNA, cas1, and direct repeat sequences also found evidence for transfer of the CRISPR 
locus in its entirety [17]. This shuffling of spacer arrays could benefit the host’s battle 
against its viral antagonists. Reassortment of CRISPR loci can redistribute beneficial 
antiviral spacers through a population, and it provides another avenue for hosts to acquire 
different spacers rather than relying solely on leader-end addition.  In addition, the 
reassortment of these loci will also prevent selective sweeps from removing 
polymorphism within a population.  Horizontal transfer of cas genes from divergent 
sources has been observed frequently in microbial populations [27,32,40,42,82].  This 
could result from a similar mechanism in which horizontal gene flow increases the 
efficacy of selection on these essential pieces of the CRISPR immunity [57,80].  This 
7 
 
observation suggests that variation in the efficiency of recombination and horizontal gene 
transfer species might impact the level of polyclonality observed within a microbial 
population. 
Model Systems for Observing CRISPR Diversity 
Simulated microbial populations 
Integrating mechanistic knowledge of CRISPR immunity, several coevolutionary models 
have been proposed (reviewed in [38]).  Many of these models predict CRISPR immune 
profiles where there is leader-end diversity but trailer-end clonality. Some models predict 
that due to the rapid acquisition of new spacers, neutral variation persists at the leader end 
until selection for a particular spacer causes a selective sweep [37]. An alternative model 
suggests that since each different spacer confers equal immunity against a given virus, 
diversity is maintained within a population because each distinct genotype has the same 
immune phenotype [18].  Although not explicitly investigated as the basis through which 
diversity is maintained, similar dynamics have been observed in other mathematical 
models [45].  Together these models suggest that biological parameters such as rates of 
viral mutation, the number of potential protospacers in the virus genome, and the 
acquisition of new spacers will result in differences in population structures between 
different host-pathogen pairs, where some stably maintain a diversity over time [45].  
As part of my research, I have demonstrated that this phenomenon emerges within 
simulated populations and quantified the extent to which this mechanism promotes 
polymorphism over time.  The impact of this type of “distributed immunity” results in 
stable and increased host populations and unstable viral populations since the advantage 
of each escape mutation has very little advantage to each viral mutant. 
Natural microbial communities of the human microbiome 
To fully realize the impact of dynamics observed in simulated populations, these 
observations must be applied to naturally occurring microbial systems.  The microbial 
communities of the human microbiome offer a rich opportunity for such study.  Viruses 
have been noted in numerous human body regions, viral communities have been studied 
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in such diverse locations as the oral cavity, skin, bloodstream, gut, and respiratory tract 
[2], and direct effects on microbial communities by phage have been observed  [72].   In 
addition to providing a scientifically useful study system, these human-associated 
communities can have serious impacts on the health of the human host, and 
understanding microbe-virus interactions could uncover information pertinent to human 
health. 
One such health-linked community is the human vaginal microbiome.  The microbial 
composition of the vagina has been implicated in complications including bacterial 
vaginosis [70,78], sexually transmitted diseases [60], and risk of preterm birth [44,69,87].  
There is no single core vaginal microbiome; rather, a set of five general types has been 
identified.  In four of these types, the microbiome is heavily dominated by a single 
Lactobacillus species (L. crispatus, L. gasseri, L. iners, or L. jensenii); the fifth is 
characterized by a consortium of strict anaerobes [71].  Regardless of community type, 
pregnancy has distinct effect on the vaginal microbiome: the community shifts toward 
lower diversity, lower anaerobe abundance, and higher Lactobacillus abundance 
[1,76,85].  The relatively low species diversity in the vaginal microbiome during 
pregnancy provides an opportunity to analyze diversity in the CRISPR system using 
metagenomic techniques, as sufficient sequencing depth of the dominant Lactobacillus 
species is more practical to achieve.  Furthermore, Lactobacillus strains commonly 
contain CRISPRs; as of the close of 2015, 63% of sequenced Lactobacillus 
representatives contain a CRISPR system  [28]. 
Using vaginal microbiome samples collected from a cohort of pregnant women at low 
and high risk for preterm birth, I extracted CRISPR spacers and characterized variation 
within and between individual women. Analyzing these CRISPRs revealed that while 
variation in spacers present between women was high, persistence of a single CRISPR-
type within an individual was common, with limited variation over the course of a 
pregnancy.  Some links between spacers and matched protospacer presence were also 
observed within one sample. 
Microbial colonization also contributes significantly to the health of individuals with 
cystic fibrosis.  Among the most common life-shortening genetic disorders, cystic 
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fibrosis results from loss of function of the cystic fibrosis transmembrane conductance 
regulator (CFTR), a chloride ion transporter. This leads to a buildup of thick, sticky 
mucus in the lungs.  In the healthy human lung, the microbiome is transient; new 
microbes are constantly introduced through inhalation and eliminated through 
mucociliary clearance [23].  However, in cystic fibrosis patients, the abnormal mucus 
prevents clearance of microbes and facilitates long-term respiratory infections, which are 
responsible for the majority of cystic fibrosis morbidity and mortality [21]. 
Among the most common and damaging of these pathogens is Pseudomonas aeruginosa, 
a ubiquitous opportunistic pathogen.  Initial colonization of the lungs is believed to stem 
from environmental strains encountered by the patient which then adapt to the lung 
environment [36].  Established  P. aeruginosa infections are extremely tough to eradicate 
due to frequent antibiotic resistance and formation of biofilms [24].   Patients are also 
susceptible to colonization by epidemic P. aeruginosa strains, which are especially adept 
at infecting cystic fibrosis patients and are associated with worse clinical outcomes [26].  
Epidemic strains are capable of infecting lungs already colonized by non-epidemic 
strains, and some of their competitive advantages have been linked to integrated 
prophages.  In the genomes of Liverpool epidemic strains (LES), disrupting some of 
these prophages put the strain at a competitive disadvantage relative to its intact ancestor 
in a rat lung chronic infection model [88].   These prophages have also been shown to 
retain their lytic activity and may affect P. aeruginosa density in the cystic fibrosis lung 
[47].  While LES strains use integrated phages to their advantage, P. aeruginosa also 
harbors a number of antiviral defenses, including a CRISPR system which is known 
provide immunity against phages [16]. Several P. aeruginosa phages are known to 
produce anti-CRISPR proteins; in fact, it was the species in which anti-CRISPRs were 
first discovered [10,11,67].   
Given the evidence for phage and prophage activity and influence on P. aeruginosa in the 
cystic fibrosis lung microbiome and the potential for P. aeruginosa CRISPRs to modulate 
phage influence, I investigated the extent of interaction with phage by assessing CRISPR 
spacer content in 14 metagenomic samples from cystic fibrosis patients.  In keeping with 
my analysis of the vaginal microbiome, no diversity was observed in P. aeruginosa 
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within a sample, but CRISPR spacer content was completely different between patients.  
To further investigate diversity in the global population, I proceeded to assess a large 
pool of P. aeruginosa genomes from varied environments.  I found a diverse array of 
spacers matching a broad variety of sequenced phage.  These diverse spacers were used 
as sequence tags for a novel method of phage tracking called prototyping which I used to 
examine the ecology of P. aeruginosa phage populations, revealing that both hosts and 
phages have a panmictic population structure.   
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CHAPTER 2 
 CRISPR-Induced Distributed Immunity in Simulated Microbial Populations1 
Abstract 
In bacteria and archaea, viruses are the primary infectious agents, acting as virulent, often 
deadly pathogens. A form of adaptive immune defense known as CRISPR-Cas enables 
microbial cells to acquire immunity to viral pathogens by recognizing specific sequences 
encoded in viral genomes. The unique biology of this system results in evolutionary 
dynamics of host and viral diversity that cannot be fully explained by the traditional 
models used to describe microbe-virus coevolutionary dynamics. Here, we show how the 
CRISPR-mediated adaptive immune response of hosts to invading viruses facilitates the 
emergence of an evolutionary mode we call distributed immunity - the coexistence of 
multiple, equally-fit immune alleles among individuals in a microbial population. We use 
an eco-evolutionary modeling framework to quantify distributed immunity and 
demonstrate how it emerges and fluctuates in multi-strain communities of hosts and 
viruses as a consequence of CRISPR-induced coevolution under conditions of low viral 
mutation and high relative numbers of viral protospacers. We demonstrate that distributed 
immunity promotes sustained diversity and stability in host communities and decreased 
viral population density that can lead to viral extinction. We analyze sequence diversity 
of experimentally coevolving populations of Streptococcus thermophilus and their 
viruses where CRISPR-Cas is active, and find the rapid emergence of distributed 
immunity in the host population, demonstrating the importance of this emergent 
phenomenon in evolving microbial communities. 
Introduction 
All organisms are susceptible to infection by viral pathogens. The sheer number of 
viruses found in natural environments is staggering; it is estimated that 10
31
 virus 
particles are circulating at any time [10,54], containing at least hundreds of thousands of 
                                                          
1
 This chapter was originally published as Childs, L.M.*, England, W.E.*, Young, M.J., Weitz, J.S., and 
Whitaker, R.J. (2014). CRISPR-Induced Distributed Immunity in Microbial Populations. PLoS ONE 9, 
e101710, and is reprinted here with permission. 
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genotypes [3], most of which infect bacteria and archaea.  Bacteria and archaea resist 
infection through random mutation, resulting in loss or modification of viral receptors, or 
through targeted defense systems such as physical blocking, restriction-modification 
systems, and abortive infection systems [8,15,33,36,47,56,63].  Both negative frequency-
dependent selection (NFDS) and diversifying selection for microbial resistance have been 
suggested to result in the diversity observed in natural systems [4,40,50].  The trade-off 
between resistance and growth rate has become the dominant model for microbe-virus 
coevolution [64], with variation in fitness driving diversification of the host and resulting 
in the predicted coexistence of many genotypes of both hosts and viruses [61].  These 
theoretically predicted trade-offs have also been seen to promote diversity of both host 
and viral populations in experimentally evolved populations [9,12,13,22,37,42].  
Recently the CRISPR-Cas system was experimentally shown to function as an adaptive 
microbial resistance mechanism, using the model organism Streptococcus thermophilus 
[5] (see reviews in [1,6,8,18,19,31,32,44,48,55,62]).  The CRISPR-Cas system, 
components of which are found in the majority of sequenced microbes [25], is comprised 
of short DNA fragments (spacers) flanked by palindromic repeats in repeat-spacer arrays 
[1].  These fragments are often identical to sequences in plasmids, viruses, and other 
foreign elements [45].  When a microbe containing an active CRISPR system encounters 
one of these foreign elements, it can add a new spacer matching a sequence in the foreign 
genome (protospacer) [5].  The CRISPR system can acquire spacers from many locations 
in a foreign genome, requiring only a short protospacer-associated motif (PAM) adjacent 
to the protospacer [18,46]. Repeat-spacer arrays are transcribed, processed, and used to 
guide an effector complex which inactivates matched foreign genetic material on any 
subsequent encounter [11].  Escape mutations in protospacers prevent recognition by the 
CRISPR-Cas system resulting in a coevolutionary dynamic in which viruses evolve 
through random mutation while hosts evolve through “directed mutation” facilitated by 
adaptive immunity [18,41,52,53].  
We propose that crucial elements of the CRISPR system result in a diversifying 
coevolutionary mode that is distinct from the traditional trade-off model described above.  
Adaptive CRISPR acquisition of new spacers leads to the potential for competing 
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CRISPR genotypes to emerge within a host population at the same (or similar) time – 
akin to the phenomena of “clonal interference” [17,24].  The vast reservoir of 
protospacers in each virus creates the potential for competing host genotypes with similar 
(or identical) resistance phenotypes that are not necessarily subject to fitness tradeoffs 
between immune alleles. In contrast, viral strains are limited in potential escape 
mutations by fitness constraints on mutations in their genomes that can modify regulatory 
elements and RNA- and protein-encoding genes.  In addition, each viral escape mutant 
only allows access to a single host immune allele, potentially composing a small subset 
of the host population [21,38].  We hypothesized that these differences would allow for a 
dramatic restructuring of the coevolutionary mode wherein many different hosts are 
immune to the same virus in different ways. We label this many-to-one, genotype-to-
phenotype phenomenon distributed immunity.  
We previously developed an eco-evolutionary model of CRISPR-mediated host-viral 
coevolution [14]. In brief, the model incorporates density-dependent Lotka-Volterra like 
ecological dynamics with the evolutionary introduction of new hosts and viral strains 
with novel genetic states. Ecological rules of interaction including host reproduction and 
death, viral infection of hosts and viral deactivation outside of hosts determine host and 
viral densities. Viral infection of hosts can lead to either host lysis or viral deactivation, 
which may occur with or without spacer integration. During replication, viral strains 
evolve through mutation generating a novel protospacer. Host immunity is determined by 
the presence of at least one spacer matching a virus, yet is not foolproof, i.e., there is a 
small chance that a host with a matching spacer to an infecting virus will not be immune 
[14].  In simulations of our model, host and viral populations oscillate in abundance over 
short time scales, whereas host and viral genotype composition changes over long time 
scales, mediated by coevolutionary adaptation. A comparison of this and other models of 
CRISPR-mediated coevolutionary dynamics (e.g., [26,27,34,39,59]), whose exact 
dynamics depend on the specific molecular, ecological and evolutionary parameters can 
be found elsewhere [14,28].  
Within our model, examining the diversity of the host population at each maximum in 
total host population abundance (host peaks), we observed two types of emergent 
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population dynamics: (i) near selective sweeps by novel or recurring strains and (ii) 
simultaneous growth of phenotypically similar but genotypically diverse groups of strains 
which we termed coalitions [14].  Although the diversification of host populations with 
CRISPR immunity had been noted previously [14,27,34,43,59], in this paper, we present 
a metric, population-wide distributed immunity (PDI) to quantify distributed immunity in 
a population, to examine how distributed immunity varies over time and to determine 
how this evolutionary mode affects the coevolutionary dynamic. We used simulated data 
from our model to: (i) determine when coalitions are characterized by distributed 
immunity; (ii) identify conditions under which distributed immunity is the dominant 
evolutionary mode in a simulation; and (iii) quantify the effects of distributed immunity 
on host-viral relationships by examining diversity and stability of host and viral 
populations. Finally we determined that the diversity exhibited in an experimental host-
viral community is associated with distributed immunity.  
Results 
Quantifying distributed immunity  
Distributed immunity denotes the emergent phenomenon in which multiple immune 
alleles coexist within and between hosts.  When these alleles are distributed between 
different hosts that have CRISPR-Cas resistance, then multiple hosts have similar 
immune phenotypes yet have distinct, coexisting associated CRISPR genotypes.   To 
measure the impact of distributed immunity, on each population, we developed a metric 
called population-wide distributed immunity (PDI) in which CRISPR-Cas immune 
relationships of all host-host-viral strain triplets are tested to determine if the two host 
strains contain spacers matching different protospacers on the same viral strain (Figure 
2.1, see Methods for details of the calculation).  The intuition behind our metric is that all 
triplets contribute positively to PDI when both hosts are immune to the virus by means of 
distinct spacers matching the virus.  In the case where both hosts are immune to the virus 
but via the identical spacer, the immunity is not distributed throughout the population and 
thus does not contribute to PDI.  Although phenotypically immunity via identical or 
distinct spacers is equivalent, the varied genotypes may follow different evolutionary 
pathways.  For example, when PDI is high, mutation of a single protospacer does not 
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permit escape in the majority of the host population. However, when PDI is low, a single 
protospacer mutation may lead to viral escape in most of the host population. The degree 
of contribution by each triplet depends on the product of the relative abundance of the 
host strains and viral strain and immunity between the host and viral strains (see Methods 
for details of the calculation). The maximum PDI for a population at any time increases 
with the number of host strains (with n host strains the maximum is 1-1/n) and is only 
obtainable when the following hold: there are at least two alleles that confer immunity to 
the viral strains, all host strains are immune to viral strains, and the abundance of each 
host CRISPR allele is equal (Figure 2.2). Note that the abundance of the viral strains does 
not affect the potential for PDI (see SI text for further discussion).  
In the simulated eco-evolutionary dynamics of hosts and viruses [14], we find that PDI 
varies through time (Figure 2.3). PDI is typically highest just prior to peaks in host 
population density and drops to at or near zero in between (Figure 2.3). Every peak of 
host density does not contain high PDI, even if its potential maximum PDI is high, and in 
our simulations we find that measured PDI is well below the potential maximum. Low 
PDI results from (i) unevenness of the host population (Figure 2.3b-1, 2.2), (ii) a large 
fraction of the hosts lacking immunity to the viral population (Figure 2.3b-2) or (iii) the 
majority of hosts having immunity to the viral population via the same spacer (Figure 
2.3b-4). In contrast, high PDI occurs when multiple hosts have unique spacers to the 
same viral strains. This can occur when a dominant host strain diversifies via the 
acquisition of unique spacers to the same viral strain (Figure 2.3b-3).  Across all 
simulations, the PDI at host peaks ranges from 0 to 0.7203 with an overall mean of 
0.0710. We find no direct, predictable relationship between the abundance of host and 
viral populations at their peaks in relation to the concurrent value of PDI within a single 
simulation.  In contrast, we hypothesize that PDI functions to alter the future host and 
viral dynamics within a community. Diversified hosts (with a high PDI) may affect the 
composition and total density of virus populations that recur in the next peak in host 
density or much later.  This is due to the complexity and diversity of both host and viral 
populations in which a particular diversified host can be targeted by divergent low 
abundance viruses that were created much earlier. 
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Parameters that increase population-wide distributed immunity 
To determine how biological parameters might influence the evolutionary mode across a 
simulation toward or away from distributed immunity, we altered four parameters that 
vary between microbial and viral strains: viral mutation rate, μ; spacer acquisition rate, q; 
maximum host spacer number, S; and viral protospacer number, P.  To avoid the period 
of transient dynamics occurring at the initiation of the simulations from a single viral and 
single host strain, we measure median PDI in the last 500 hours of each simulation, 
where the host spacer locus is filled and both host and viral diversity are most regular 
(see SI text, Figure 2.4). Comparing the population dynamics between sets of simulations 
with varying parameters, we found that average PDI across the simulations increases 
when viral mutation rate decreases and when the number of relative protospacers 
increases (Figure 2.5). There are also increases in PDI when the spacer acquisition rate 
increases and the number of spacers increases, but PDI above 0.1 is rarely seen (Figure 
2.5). The highest average PDI is seen with high relative protospacer number (P=20) and 
low viral mutation rate (μ= 10-7) while lowest average PDI occurs with low relative 
protospacer number (P=5) and low spacer acquisition rate (q=10
-6
).  Increases in average 
PDI result from coevolutionary dynamics that include more host population peaks with 
higher PDI, rather than from an increase in PDI when host populations are not near their 
peak values.  
Population-wide distributed immunity is associated with individual distributed immunity 
In simulations with a higher average PDI, we observed an additional dynamic where 
individual host genotypes contain multiple spacers matching the same viral strain at 
distinct protospacers.  This represents an analogous form of distributed immunity, albeit 
within a single host.   Since this will have similar evolutionary effects as PDI, we 
quantify the average per host immunity to viral strains with a new metric denoted as 
individual distributed immunity (IDI).  IDI is equal to the average number of distinct 
matching spacers between each pair of viral and host strains (see Methods for details of 
the calculation).  When IDI is greater than one, the host population is on average immune 
in multiple ways to the viral population due to targeting multiple regions of the viral 
genome. We find that there is strong correlation between PDI and IDI (Figure 2.6) and, as 
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with PDI, there is high IDI with low viral mutation rate and high protospacer number 
(Figure 2.7).  Hereafter, we collectively refer to PDI and IDI as DI. 
Elevated distributed immunity is associated with increases in host diversity, density, and 
stability 
Having identified conditions under which simulations with high levels of distributed 
immunity are linked to changes in host-virus relationships, we investigated possible 
consequences of these altered interactions.  We found that simulations resulting in high 
levels of distributed immunity are correlated with increased host strain count and 
population density (Figure 2.8A-D).  We find a much stronger association between DI 
and these population level indicators than when evaluating the statistical relationship 
between mutation rate and protospacer number alone.  For example, the Spearman rank 
correlation coefficient between host population density and PDI is 0.84 whereas it is -
0.31 and 0.49, when evaluated against mutation rate and P, respectively (all p<0.001).  
Similarly, the Spearman rank correlation coefficient between host strain count and PDI is 
0.78 whereas it is -0.26 and 0.27, when evaluated against mutation rate and P, 
respectively (all p<0.001).   The data collapse of host population density and host strain 
count as a function of PDI from simulations with different governing parameters is 
apparent in Figure 2.8A-D. Investigating simulations where distributed immunity has a 
strong effect (high DI), we also observed extended periods of high density, stable host 
populations (see time points between 9700-10000 in Figure 2.9A-C for a typical 
example). Periods of stable host-controlled dynamics occur exclusively in parameter sets 
which have higher DI: P=15, P=20, and μ=10-7, and the proportion of simulations which 
exhibit extended stable periods increases with increasing DI (Figure 2.9E, black bars). 
The finding of extended stability is not driven solely by the extended high host density; 
this pattern is observed whether DI is measured at all time points (as in Figure 2.9E), or 
only at host density peaks.  
Elevated PDI is associated with decreased viral diversity and density  
In contrast to the increases in host population density and host strain count as PDI 
increases, the trends for viral population density and viral strain count are non-monotonic 
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(Figure 2.8E-H and S5). At lower PDI (PDI < 0.2) increases in PDI correlate with 
increases in viral population density and weakly correlate with increases in viral strain 
count (Figure 2.8 and 2.10). The observed viral population increases are also correlated 
with increases in host population size and host immunity (Figure 2.11). Although 
immunity is increasing, it is still relatively low, suggesting that individual viral strains 
can continue to grow on subsets of the total host population. Simultaneously, as PDI 
increases, the host population is also increasing, so that each subset of hosts that viruses 
can infect is actually larger than at lower PDI. At higher PDI (PDI > 0.2), increases in 
PDI correlate with decreases in viral population density and viral strain count (Figure 
2.8). Beyond PDI = 0.2, increases in host population size and immunity no longer 
correspond to higher viral densities.  This decrease in viral density is consistent with the 
fact that the proportion of hosts that viruses can infect (HVI, see Methods for details of 
the calculation) decreases as DI increases, and HVI is significantly lower in simulations 
with higher DI (Figure 2.12). Accompanying decreases in viral population sizes we find 
that the proportion of simulations in which viruses go extinct increases with increasing 
DI (Table 2.1 and Figure 2.13, dark gray bars).  Parameter sets with the highest DI, P=20 
and μ = 10-7, result in viral extinction in 10% and 12% of simulations with filled loci, 
respectively, the highest rates of extinction of any parameter set (Table 2.1). Considering 
simulations in which the CRISPR locus does not fill before the last 500 hours, 90.7% end 
in viral extinction, including 94.3% and 91.6% of P=20 and μ = 10-7 simulations, 
respectively. Nearly all simulations with lower DI reach a full spacer locus prior to the 
final 500 hours (Table 2.1). 
Elevated distributed immunity identified in an experimental viral-host community 
We examined whether the dynamic of distributed immunity observed in simulations is 
consistent with patterns observed in experimental microbial communities in which both 
virus and host sequence is known. To do so, we estimated DI within an experimental set 
of host and viral populations. A quantitative assessment of the contribution of the relative 
DI to the maintenance of diversity in natural microbial populations is not possible in most 
studies, as the contemporary virus population is not typically sequenced. Despite 
technical challenges to date in testing distributed immunity in natural populations, studies 
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in laboratory populations offer an opportunity to measure distributed immunity. 
Numerous studies in laboratory populations have shown that upon challenge by a single 
phage, multiple S. thermophilus genotypes emerge with different spacers providing 
immunity [5,18,32,41,49,53]. For our analysis, we used data from Sun et al. [53], the 
only study with both sequences and abundances from the entire coevolving host and viral 
populations as required to measure DI.  In this study, a laboratory-coevolved population 
of Streptococcus thermophilus and its phage 2972 was found to exhibit rapid spacer 
addition as well as phage CRISPR escape mutations.  After 1 week of co-culture, the host 
had added 43 new spacers to one CRISPR locus, and three viral mutations in targeted 
protospacers or PAMs were detected [53].  Given the diversity of new spacers matching a 
small pool of viral types, we estimated a high value of PDI for these populations. Using 
populations reconstructed from spacer-containing reads and viral SNP distributions 
(Figure 2.13, see Methods), the value of PDI after 1 week of coevolution was 0.4331, out 
of a maximum possible PDI of 0.5933.  This estimate of elevated PDI complements Sun 
et al.’s [53] observation of multiple acquisitions of distinct CRISPR escape mutants, and 
suggests a population-level effect that may act synergistically with individual host-viral 
interactions.  Note that this PDI value is larger than the median PDI in 99.8% and the 
highest observed PDI in 75.9% of all simulations we conducted. The value of IDI, 
1.2264, was higher than the median IDI in 97.7% and the highest observed IDI in 58.7% 
of simulations. 
Discussion 
We have explored the immune dynamics resulting from a computational eco-evolutionary 
model driven by CRISPR-mediated immunity. The model demonstrates how a host-viral 
community can evolve a complex structure where different hosts are immune to the same 
virus as a result of immunity conferred by different immune alleles, which we have 
quantified as distributed immunity. Immunity relationships between hosts and viruses 
with distributed immunity may appear similar from the phenotype level to relationships 
lacking distributed immunity; however, the underlying genetic diversity present in 
distributed immunity changes the dynamics of coevolution. In particular, during periods 
of elevated distributed immunity, the host population is diverse and stable while the viral 
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population is restricted in the number and extent of possible beneficial mutations and is 
prone to extinction. The stable maintenance of multiple non-dominant genotypes that 
accompanies distributed immunity is likely facilitated by NFDS.   The generation of 
distributed immunity and the selective mechanisms of NFDS may work together to 
promote diversity. 
Several CRISPR models have previously observed diversity in host spacer content both at 
an individual and population level [14,27,34,59], but understanding that diversity has 
been a recent exploration. Although Iranzo et al. [34] established several population-level 
findings, such as CRISPR immunity promoting the coexistence of viruses and hosts at 
intermediate viral mutation rate and the lack of increased viral diversity with CRISPR 
immunity, they did not attempt to expound upon these findings, which they labeled 
counterintuitive. Our model, even with its reduced complexity as we ignore populations 
lacking CRISPRs, is able to reproduce these results and offer an explanation for them via 
distributed immunity. Here, we have demonstrated that the consequences of viral 
protospacer number and mutation rate as well as host spacer acquisition rate and spacer 
number on the population dynamics can be explained as acting through distributed 
immunity thereby linking the molecular and evolutionary mechanisms to the eco-
evolutionary dynamics that have been observed.  Since distributed immunity only 
requires some of the spacers to be distinct, it is consistent with a previously posed model 
where random deletion lead to selective sweeps of trailer-end spacers [59].   
CRISPR-Cas diversity varies greatly among systems.  At one end of the spectrum are the 
slowly-evolving CRISPR-Cas systems of Escherichia and Salmonella, where estimates 
indicate that strains that have diverged in the last thousand years have identical CRISPR 
loci [57]. At the other end are natural populations exhibiting high CRISPR-Cas diversity, 
including the human gut microbiome [51], Yersinia pestis plague foci [16], and hot spring 
populations of Sulfolobus islandicus [29,30].  Notably, in the case of S. islandicus, these 
archaeal populations do not contain a dominant genotype or display evidence of selective 
sweeps over a ten-year interval [30] but maintain diversity at both the leader and trailer 
ends of the CRISPR loci over time.  Some natural populations demonstrate evidence of 
past selective sweeps in the form of conserved trailer-end spacers, particularly 
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populations of acidophilic microbes found in acid mine drainage [2,58,59].  The 
difference between the immune structures of different microbial populations may be 
driven by differences in the extent of distributed immunity within populations, 
differences in the levels of reassortment of CRISPR alleles between strains in different 
populations [30], or the action of other host defense systems operating along with 
CRISPR-Cas immunity.   
Indeed, our model suggests that the biology of CRISPR-Cas system might define the 
resulting level of diversity observed in natural populations.  We show that the number of 
protospacers, viral mutation rate, and host acquisition rate all significantly influence the 
level of distributed immunity in a way that would result in different immune structures in 
natural populations.  These factors have been shown to vary in natural microbial 
populations.  For example, in microbes with active CRISPR-Cas defense, the number of 
protospacers is determined by both the length of the viral genome and the length and 
sequence of the PAM sequences, which direct acquisition and interference.  We infer that 
protospacer number is positively correlated with distributed immunity because at higher 
protospacer numbers it is easier for hosts to acquire multiple spacers to the same virus 
(higher IDI) and for different hosts to acquire different spacers (higher PDI). We 
hypothesize that microbial hosts utilizing shorter PAMs or that are infected by viruses 
with larger genomes are more likely to display a diversified immune structure that is 
consistent with distributed immunity. Variation in viral mutations rates has also been 
observed in natural populations.  For example, it has been suggested that thermophiles 
and their viruses have lower mutation rates than their mesophilic counterparts [20,60].  
Our model suggests that this is consistent with data showing that the thermophilic 
archaeon S. islandicus appears to maintain a stable diversified population over time 
[29,30]; however, this hypothesis must be explicitly tested. Finally, in this study we did 
not explore variation in the probability that CRISPR immunity fails such that a host cell 
does not recognize and clear a virus for which it has a matching spacer. Such failure may 
result in the proliferation of a virus to which there exists some immunity in the 
population. Given our previous analysis showing the relatively minor effects of such 
failure on resulting dynamics [14] , we do not expect significant effects of the stochastic 
failure of host spacers on distributed immunity, at least in the range of failure values 
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observed experimentally [5].  However, in the case of exposure to plasmids rather than 
viruses, such failure may permit the exchange of genetic material between hosts [35]. 
Under conditions when genetic exchange is advantageous (e.g., in the presence of many 
beneficial plasmids [23]) then the occurrence of distributed immunity may result, even if 
seemingly unfavorable, to protect against virulent viruses.  
Although natural population data is not yet available to employ our novel metrics PDI 
and IDI for quantifying distributed immunity, we have quantified this evolutionary mode 
in an experimental population. Qualitatively, Sun et al. [53] observed rapid transition 
from clonal to diversified in both host and viral populations as a result of CRISPR-Cas 
immunity. We demonstrated that this diversification also exhibited rapid emergence of DI 
and hypothesize that our finding of highly elevated PDI in Sun et al. [53] may be due, in 
part, to the relatively large number of protospacers in the genomes of phage (associated 
with replete PAMs), as compared to the use of low number of protospacers (P = 5-20) in 
our models due to computational constraints. This hypothesis is further supported by our 
simulation results where DI increases as we increase protospacer number (see Figure 
2.5A).   We predict that in this system when the S. thermophilus hosts exhibit distributed 
immunity, viral populations will be smaller, less diverse and more prone to extinction. 
We consider it an important future goal to extend the DI analysis of S. thermophilus and 
phage to systems in which host and viral metagenomes are available to further quantify 
the variation of DI in natural populations.   
A better understanding of CRISPR-mediated coevolutionary dynamics will have 
important implications for medical applications for example those seeking to target 
microbial pathogens with phage therapy.  In addition, our model suggests possible 
optimal strategies for engineering stable microbial communities immune to phage attack 
such as those used in biofuels production or other industrial applications. Finally, 
CRISPR immunity serves as an interesting model system in which to study the broader 
effects of diversified immunity on pathogen evolution. Such diversity impacts the 
trajectory of host-virus coevolution in microbes mediated by CRISPR-Cas immunity. 
Further understanding how distributed immunity affects the evolutionary path of 
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populations may yield insight into the effects of host immune diversity in microbial 
communities and other systems. 
Methods 
Model information and statistical analyses 
We use the model introduced in Childs et al. [14] to generate our simulation data. Briefly, 
in the model, ecological host-viral dynamics are combined with the introduction of new 
host and viral strains through changes in the CRISPR space and protospacer states.  Hosts 
may acquire new spacers during viral infection, and viruses may mutate to novel 
protospacers during replication. Host immunity towards an infecting virus requires the 
presence of at least one spacer matching a viral protospacer, but is not full proof. The 
population dynamics of host and viral strains are deterministic but the incorporation of 
hosts’ spacers and mutation of viral protospacers occurs stochastically. Further details of 
the model are reviewed in the supplemental information with the parameters used in 
Table 2.2. Although this paper focuses on four parameters (protospacer number, spacer 
number, viral mutation rate, spacer acquisition rate), Childs et al. [14] more thoroughly 
tests dependencies of model dynamics on other parameters.  Due to the stochastic nature 
of our model, the parameter regions surveyed were limited by computational cost. All 
results presented are averages of 200 replicate simulations, unless otherwise noted (Table 
2.1), with each replicate represented by the median value across the final 500 hours of 
that simulation. One hour is equivalent to the inverse of the growth rate – what we denote 
here as a typical host generation time.  Simulations were excluded from population 
averages whenever the spacer states did not contain the maximum number of spacers (full 
locus) throughout the final 500 hours of simulation or whenever the viral population fell 
below our density cutoff before the locus was filled (Table 2.1).  
For each of the four parameters varied (protospacer number, spacer number, viral 
mutation rate, spacer acquisition rate), measurements from replicates at each parameter 
value tested were grouped. The means of replicate PDI and IDI measurements were 
compared using analysis of variation for unbalanced data (data from Figures 2.5 and 2.7).  
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The Spearman rank correlation coefficients were determined for variations in each 
parameter between PDI, host population density, viral population density, host strain 
count, viral strain count, and IDI (data from Figures 2.5, 2.6 and 2.7). The Spearman rank 
correlation coefficients were also determined for variations in PDI, host population 
density and immunity combining all parameter sets (data from Figure 2.11). R
2
 values 
were determined for correlations between HVI and PDI, and between HVI and IDI (data 
from Figure 2.12). 
The data collapse of host and viral output variables, as a function of PDI, from 
simulations with different governing parameters is apparent in Figures 4 and S5.  To test 
for correlations, linear R
2
 values were determined for variations in each parameter 
between PDI, host population density, viral population density, host strain count, viral 
strain count and IDI for variations in each parameter (data from Figure 2.8, 2.10). Despite 
significant linear correlation in almost all cases, except between PDI, host strain count 
and viral strain count when varying S, it was evident upon inspection that the 
relationships between PDI and viral population density and viral strain count were better 
described by non-linear functions, particularly quadratic functions. To quantify this, we 
fit a quadratic model for viral output parameters and compared the quality of fit to a 
linear model using AIC; the relationship of all PDI and viral output statistics were better 
fits as demonstrated by lower AIC values except for PDI and viral strain count when 
varying S where both linear and quadratic fits were not significant (see Table 2.3). 
To compare the proportion of simulations that are stable, fluctuating, or end in viral 
extinction, 10,000 random subsamples of 230 simulations (10% of the total simulations 
with filled loci) were taken.  The mean proportions of simulations in each bin that fell 
into the stable or viral extinction category were compared using analysis of variation 
(data from Figure 2.13). We define a population to be stable when the host population 
exceeds 3e5 for more than 100 hours (approximately 95% of the carrying capacity).    
Population-wide distributed immunity (PDI) 
To quantify the population-level distribution of immune alleles between hosts with 
similar immune phenotypes but distinct CRISPR genotypes, we compare all triplets of 
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two host strains and a viral strain. We determine which triplets contain distinct spacers 
matching protospacers in the virus to quantify PDI as follows: 
 
where Ni is the population proportion of the i
th
 host strain, Vk is the population proportion 
of the k
th
 viral strain, Gi is the set of spacers belonging to the i
th
 host strain, Hk is the set 
of protospacers belonging to the k
th
 viral strain, R(Gi ,Hk) determines the number of 
matching spacers and protospacers between the states Gi and Hk, and R(Gi ,Gj ,Hk) 
determines the number of matching spacers and protospacers between all the states Gi, Gj 
and Hk. Further, max(N) denotes the maximum proportion of any given host strain in the 
population.  
Triplets with matching spacers and protospacers contribute to PDI via the function σ. The 
relative of abundance of the strains from a triplet determines the level of contribution of 
that triplet to PDI. The total value of PDI is weighted by host strains at or similar to the 
size of the dominant host strain in order to minimize the summed contribution of 
numerous strains found at low proportion.  
Individual distributed immunity (IDI) 
We introduce individual distributed immunity to quantify the distribution of immunity 
within hosts, in contrast to PDI, which quantifies the distribution of immunity between 
hosts. IDI is the average number of spacers per host matching the viral population: 
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where the host proportion (Ni), the viral proportion (Vk), the host spacer state (Gi), the 
viral spacer state (Hk), and the number of matches between  spacer and protospacer states 
R(Gi,Hk) are defined as in PDI.  
Hosts that Viruses can Infect (HVI) 
The average proportion of hosts that viruses can infect is quantified by HVI: 
 
where M(Gi ,Hk) determines the presence or absence of matching spacers and 
protospacers between the states Gi and Hk. The host proportion (Ni), the viral proportion 
(Vk), the host spacer state (Gi), the viral spacer state (Hk) are defined as in PDI. 
Experimental population DI calculations 
Sequencing reads from the Sun et al. study [53] (accession number SRA049615) 
containing at least two novel spacers, or at least one novel spacer plus ancestral spacers 
or leader sequence were considered.  Reads were grouped by spacer content; where 
trailer-end sequence information was not available, the locus was assumed to have the 
same trailer-end spacers as other reads with similar leader-end spacer content (Figure 
2.14).  If trailer end spacers could not be inferred in this way, the trailer end was assumed 
to contain only spacers fixed in the population (Figure 2.14). Each unique set of spacers 
was considered a host strain; the proportion of reads matching each strain was used for 
the proportion of each strain in the population (Ni and Nj) for calculation of PDI and IDI.  
Assuming similar CRISPR loci whenever possible maximizes the number of reads 
grouped into each CRISPR-type and prevents overestimation of PDI.   
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Frequencies of three phage mutations in protospacers or PAMs identified by Sun et al. 
[53] were confirmed using breseq [7](available online at http://barricklab.org/breseq).  
Each possible combination of SNPs was considered a different viral strain. To determine 
the proportion of phages with each combination of SNPs (SNP-i only, SNP-i and SNP-ii, 
SNP-i and SNP-iii, or all three SNPs), each mutation was considered an independent 
event and the probability of each combination was calculated. These proportions were 
used for Vk in the PDI and IDI equations.  Otherwise, PDI and IDI were calculated as in 
simulated populations. 
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Figures and Tables 
 
Figure 2.1. Population distributed immunity (PDI) depends on immunity relationships 
between hosts (circles and viruses (hexagons). Immune elements are denoted as linear arrays of 
boxes.  PDI is the sum of contributions (δPDI) calculated amongst triplets of two hosts and one 
virus, adjusted by their population proportions, as follows: (A) δPDI = 0 when only one (or 
neither) hosts in a triplet match the virus as R(N1,V1)=M(N1,V1)=0, R(N1,V1)=M(N1,V1)=1,and 
R(N1,N2,V1)=0.  (B) δPDI = 0 when both hosts match the virus with the same spacer as 
R(N1,V1)=M(N1,V1)=1, R(N1,V1)=M(N1,V1)=1,and R(N1,N2,V1)=0. (C) δPDI = N1N2V1{1-[|N1-
N2|/max(N1,N2)]} when both hosts match the virus via different spacers as R(N1,V1)=M(N1,V1)=1, 
R(N1,V1)=M(N1,V1)=1,and R(N1,N2,V1)=1. Identical colors, indicated by arrows, represent 
matching spacer-protospacer pairs. White protospacers and spacers are unique.   
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Figure 2.2. Maximum possible PDI changes with the number of host strains. The maximum 
attainable PDI is determined by the number of host strains, the evenness of the host abundances 
and requires all host strains are immune to all viral strains. Maximum PDI increases towards one 
when all hosts have equal abundance (blue). When one host dominates, for example 50% of the 
population (green) or 90% of the population (red), and all other hosts have equal abundance, the 
maximum PDI is significantly reduced. 
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Figure 2.3. Host populations exhibit periods of different coevolutionary dynamics. (A) 
Population dynamics of the host (top) and virus (middle) and PDI (bottom) from a representative 
simulation. Each color represents a host or viral strain with a unique spacer or protospacer set and 
is proportional in height to the strain proportion in the population; colors repeat when not 
touching. (B) Spacer-protospacer matches between major host and viral strains at four time points 
as examples of single-strain dominance (1), coalitions with low immunity (2), coalitions with 
high PDI (3), and coalitions with high immunity but low PDI (4). The spacer and protospacer 
composition of each host or viral strain, respectively, is listed horizontally. The number in the 
first column indicates the proportion of each strain in the population, while the remaining boxes 
represent the spacer or protospacer state.  Host strains making up less than 2% and viral strains 
making up less than 5% of the population, which only have minor impact on the calculated PDI, 
are omitted for space. Matching colors in host and viral boxes indicate a spacer-protospacer 
match. White boxes are spacers or protospacers without a match. Model parameters are standard 
parameters in Table 2.2. 
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Figure 2.4. Early time course of a representative simulation with standard parameters listed 
in Table 2.2. Despite seeding with a single host and viral strain, many strains rapidly appear as 
result of the ever-changing immunity structure. Thick lines at the top of panels A and B are total 
population density; thin lines are population density of individual host strains (blue lines, A) and 
viral strains (red lines, B). During the initial hours there is more defined population strain 
structure when the average spacers per host is low (C). 
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Figure 2.5. PDI is elevated at high protospacer number and low viral mutation rate. 
Measured PDI in numerical simulations is shown with varying (A) protospacer number; (B) host 
acquisition rate; (C) viral mutation rate; (D) spacer number. Bars (and lines) represent mean (and 
SEM) of PDI of replicate simulations, with each replicate represented by the median value across 
the final 500 hours of that single simulation. Unless varied, parameters are S=10, P=10, q=10
-5
, 
μ=5x10-7. Using analysis of variation for unbalanced data all pairwise comparisons of mean PDI 
are significant at p<0.001 except comparisons between: μ=5x10-7 and μ=7.5x10-7 (p<0.01) in (C); 
μ=7.5x10-7 and μ=10-6 (not significant) in (C); and q=5x10-5 and q=10-4 (not significant) in (D). 
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Figure 2.6. PDI is positively correlated with IDI. Each point is the median from last 500 hours 
of a single simulation varying (A) protospacer number, P; (B) spacer number, S; (C) viral 
mutation rate, μ;  (D) host spacer acquisition rate, q. Unless varied, S=10, P=10, q=10-5,  
μ=5x10-7. r2 correlation coefficients, noted in the upper-right corner of figure panels, of all 
comparisons are significant at p<0.001. Correlations are depicted with solid black lines. 
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Figure 2.7. IDI varies with: (A) protospacer number; (B) spacer number; (C) viral mutation 
rate; (D) spacer acquisition rate. Unless varied, S=10, P=10, q=10
-5, μ=5x10-7.  Bars (and lines) 
are mean (and SEM) of IDI of replicate simulations, with each replicate represented by the 
median value across the last 500 hours. Using analysis of variation for unbalanced data all 
pairwise comparisons of mean PDI are significant at p<0.001 except in (D) where all pairwise 
comparison with q>1e-6 (not significant). 
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Figure 2.8. PDI and population measures when varying mutation rate and protospacer 
number. High PDI is associated with (A-B) increases in host population density, (C-D) increases 
in host strain count, non-monotonic changes (E-F) in viral population density, and non-monotonic 
changes (G-H) in viral strain count. Left column is varying mutation rate, μ, and right column is 
varying protospacer number, P. Unless varied, parameters are S=10, P=10, q=10
-5, μ=5x10-7. 
Each point is the median from the last 500 hours of a single simulation.  Note that both viral  
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Figure 2.8. (cont.) 
population density and viral strain count are unimodally related to PDI, with the lowest levels of 
both viral population density and strain count occurring at high PDI. The Spearman rank 
correlation coefficients of all comparisons, noted in the upper right corner of Figure panels, are 
significant at p<0.001. These relationships, including those that are non-monotonic, are discussed 
further in the main text. 
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Figure 2.9. Host stability in a high DI population. (A) Plot of host dynamics for a 
representative model simulation containing an extended period of host population stability.  Each 
color represents a host strain with a unique spacer set and color height is equal to population 
proportion of the strain; colors repeat when not touching. (B) Total population density in log-
scale of host (blue) and virus (red) strains. (C) PDI (magenta, left y-axis) and IDI (green, right y-
axis) metrics. (D) Spacer-protospacer matches at 9800 hours.  The spacer and protospacer 
composition of each host or viral strain, respectively, is listed horizontally. The number in the 
first column indicates the proportion of each strain in the population, while the remaining boxes 
represent the spacer or protospacer state. Strains making up less than 5% of the population are 
omitted for clarity.  (E) Numbers at the top of each bar designate the total number of simulations 
in each bin. A simulation is denoted as “stable” when the host population remains above 3x105 
(close to carrying capacity) for at least 100 consecutive hours, and as “viral extinction” if the 
simulation ends prior to the designated endpoint due to reaching a viral population size below our 
density cutoff of 0.1/mL.  Comparisons of subsampled data for stable and viral extinction show 
significant differences between means of all PDI bins (except between 0-0.1 and 0.1-0.2 stable 
simulations) and all IDI bins (except between 1.8-2.4 and 2.4-3.0 stable simulations). 
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Figure 2.10. PDI and population measures when spacer acquisition rate and spacer number 
are varied. PDI is only weakly correlated, if at all, with host population density (A-B), host strain 
count (C-D), viral population density (E-F) and viral strain count (G-H) across variation in spacer 
acquisition rate, q (left column), and spacer number, S (right column). Unless varied, S=10, P=10, 
q=10
-5, μ=5x10-7. Each point represents the median of the last 500 hours in a single simulation. 
Linear R
2
 correlation coefficients (A-D) and quadratic R
2
 correlation coefficients (E-H), noted in  
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Figure 2.10. (cont.) 
the figure panels, of all comparisons are significant at p<0.001 except PDI with host strain count 
(in D) and PDI with viral strain count (in G) when spacer acquisition rate is varied. Correlations 
are depicted with solid black lines (A-D) and curves (E-H). 
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Figure 2.11. Low PDI (< 0.2) is correlated with increases in immunity (A) and host 
population density (B). At high PDI (> 0.2) immunity (A) and host population density (B) are 
uniformly high. Each point represents the median of the last 500 hours of a single simulation; all 
parameter sets from Table 2.1 are included. R2 correlation coefficients (A) 0.59 and (B) 0.78 are 
significant at p<0.001.  
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Figure 2.12. HVI decreases with increasing PDI (A-C) and IDI (D-F). PDI values binned by 
0.1; IDI values binned by 0.6. Bars (and lines) are mean (and SEM) of median HVI across the last 
500 hours of each replicate simulation from a pool of 100 simulations per parameter set. 
Parameters for each panel are (A,D) S=10, P=10, q=10
-5, μ=5x10-7; (B,E) S=10, P = 20, q=10-5, 
μ=5x10-7; (C,F) S=10, P=10, q=10-5, μ = 10-7. All other parameters as listed in Table 2.2. R2 
values (data not binned) are noted in each panel with *, p < 0.01,;**, p << 0.001; NS, not 
significant. 
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Figure 2.13.  PDI and IDI estimated in a population of Streptococcus thermophilus and its 
phage 2972. Data from [53] (accession number SRA049615).  Virus protospacer and host spacer 
states are shown after one week of experimental coevolution. Matching colors in host and viral 
boxes indicate a spacer-protospacer match. White boxes are spacers or protospacers without a 
match.  All viruses are shown; host strains that make up less than 3% of the population are not 
shown for clarity.  Protospacer positions for which there is no match between any virus and the 
hosts shown are omitted. 
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Figure 2.14. Example of methodology of CRISPR locus reconstruction from sequencing 
reads.  Each color represents a unique spacer. Each horizontal row on the left shows the spacer 
content of a single read; its corresponding row on the right shows the inferred complete spacer 
content.  The spacer marked with an asterisk is not present in the ancestral host but has become 
fixed in the current population. L, leader sequence; T, spacers present in ancestral host. 
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Table 2.1. Summary of simulated population outcomes. Summary of the population outcomes 
(complete, viral extinction, unfilled locus) of simulations for each parameter set. 
S P μ q Complete 
Viral 
Extinction
* 
Unfilled 
Locus Total 
Simulation 
Length (h) 
5 10 5.0E-07 1.0E-05 200 0 0 200 2500 
10 5 5.0E-07 1.0E-05 200 0 0 200 2500 
10 10 5.0E-07 1.0E-05 199 0 1 200 2500 
10 15 5.0E-07 1.0E-05 183 2 15 200 10000 
10 20 5.0E-07 1.0E-05 132 15 53 200 10000 
10 10 1.0E-07 1.0E-05 29 4 167 200 2500 
10 10 2.5E-07 1.0E-05 173 0 27 200 2500 
10 10 7.5E-07 1.0E-05 200 0 0 200 2500 
10 10 1.0E-06 1.0E-05 199 0 1 200 2500 
10 10 5.0E-07 1.0E-06 148 16 36 200 2500 
10 10 5.0E-07 5.0E-06 198 0 2 200 2500 
10 10 5.0E-07 5.0E-05 200 0 0 200 2500 
10 10 5.0E-07 1.0E-04 200 0 0 200 2500 
* Viral population falling below density cutoff (0.1/mL) during the last 500 hours of the 
simulation.   
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Table 2.2.  Model parameters. Description of parameters including symbol and value used for 
simulation of the model. 
Parameter Description 
Standard 
value Other values 
p CRISPR failure probability 1.0e-05 -- 
q 
spacer acquisition 
probability 1.0e-05 1.0e-06, 5.0e-06, 5.0e-05,  
1.0e-04 
r growth rate (1/h) 1 -- 
K carrying capacity (1/mL) 1.0e5.5 -- 
β burst size 50 -- 
Φ adsorption rate (mL/h) 1.0e-07 -- 
m viral decay rate (1/h) 0.1 -- 
μ mutation rate 5.0e-07 1.0e-07, 2.5e-07, 7.5e-07,  
1.0e-06 
ρ density cutoff (1/mL) 0.1 -- 
S number of spacers 10 5 
P number of protospacers 10 5, 15, 20 
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Table 2.3.  Linear - quadratic model comparisons. Summary of the R
2
 computation for Figure 
2.8E-H and Figure 2.10E-H and choice of model fit using AIC. 
Parameter Type Description R
2
 AIC p Figure 
μ linear PDI vs. viral population 
density 
0.10 26460 <0.001 2.8E 
 quadratic PDI vs. viral population 
density 
0.66 25674 <0.001 2.8E 
P linear PDI vs. viral population 
density 
0.01 23960 <0.001 2.8F 
 quadratic PDI vs. viral population 
density 
0.69 23129 <0.001 2.8F 
μ linear PDI vs. viral strain count 0.19 10425 <0.001 2.8G 
 quadratic PDI vs. viral strain count 0.20 10422 0.02 2.8G 
P linear PDI vs. viral strain count 0.06 8966 <0.001 2.8H 
 quadratic PDI vs. viral strain count 0.40 8648 <0.001 2.8H 
q linear PDI vs. viral population 
density 
0.60 30410 <0.001 2.10E 
 quadratic PDI vs. viral population 
density 
0.67 30229 <0.001 2.10E 
S linear PDI vs. viral population 
density 
0.48 11988 <0.001 2.10F 
 quadratic PDI vs. viral population 
density 
0.57 11913 <0.001 2.10F 
q linear PDI vs. viral strain count 0.20 11382 <0.001 2.10G 
 quadratic PDI vs. viral strain count 0.26 11313 <0.001 2.10G 
S linear PDI vs. viral strain count 0.00 4575 0.80 2.10H 
 quadratic PDI vs. viral strain count 0.00 4575 0.17 2.10H 
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CHAPTER 3 
 CRISPR Diversity in the Vaginal Microbiomes of Pregnant Women  
Abstract 
The vaginal microbiome has a significant impact on womens’ health, including 
connections to preterm birth risk; however, the role of bacteriophages in these 
communities is largely unstudied. The CRISPR system, a microbial immune system 
which stores pieces of foreign DNA, has the potential to offer insight into how these 
microbes interact with their viruses.  We employed a network-based method to identify 
CRISPRs from all possible species in metagenomic data from the vaginal microbiota of 
ten women over the course of their pregnancies; five of whom were at high risk for 
preterm delivery and five of whom were low-risk.  We identified over 20 types of 
CRISPRs, with variation in spacer content among individuals.  We found evidence of 
multiple coexisting CRISPR alleles, CRISPR change via spacer addition over time, and 
CRISPR-linked shifts in protospacer abundance in CRISPRs from Lactobacillus iners in 
one of our subjects, demonstrating that our method is capable of detecting CRISPR 
variation in metagenomic samples and that CRISPRs are actively interacting with foreign 
elements in the vaginal microbiome. 
Introduction 
The human vaginal microbiome consists of a community of microbes with implications 
for health and disease.  Microbial composition has been linked to a range of medical 
complications such as bacterial vaginosis [21,29], sexually transmitted diseases [17], and 
risk of preterm birth [14,19,33].  Though studies have not supported a single core vaginal 
microbiome [22], a series of community groups (called Types I-V) dominated by a single 
Lactobacillus species or a consortium of strict anaerobes have been identified [22].  
Lactobacillus is traditionally associated with a healthy state, producing lactic acid to 
maintain appropriate vaginal pH, while a community dominated by anaerobes is 
diagnostic of bacterial vaginosis [20].  The microbial community can change over time, 
both short-term fluctuations and in response to major events such as pregnancy.  During 
pregnancy, the vaginal community is characterized by lower species diversity, higher 
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Lactobacillus abundance, and lower abundance of anaerobic microbes present in Type IV 
communities [1,26,32].  The vaginal microbial community is also linked to preterm birth; 
reproductive tract infections are a major cause of preterm birth [10], and a correlation has 
been found between preterm birth and lower vaginal community diversity [14]. 
Compared to what is understood about the effects of the bacterial communities of the 
vagina, relatively little is known about the role of bacteriophages in these communities.  
Prophage induction in lactobacilli has been posited to contribute to development of 
bacterial vaginosis by killing off resident lactobacilli, allowing vaginosis-linked species 
to proliferate [30], and these prophages have also been proposed to be influential agents 
of horizontal gene transfer in the vaginal microbiome [4]. However, the ecology of phage 
populations and how bacterial hosts modulate their interactions with these phages 
through resistance and immunity mechanisms has not been thoroughly studied. 
One immunity mechanism which holds promise for investigating bacteria-phage 
interactions is the CRISPR system, an adaptive microbial immune system which is 
present in 50% of sequenced bacteria [16].  The CRISPR system consists of arrays of 
palindromic repeats interspersed with spacers, or short DNA fragments which frequently 
match segments of foreign genetic elements such as viruses, plasmids, and transposons 
[18].  The spacer-matched sequences in these elements are referred to as protospacers. 
Hosts harboring CRISPRs can add new spacers to their repeat-spacer arrays in a polar 
manner, with the end to which new spacers are added called the leader [3].  The complete 
repeat-spacer array is transcribed and processed into crRNAs, each of which holds the 
sequence of an individual spacer.  These crRNAs are used to guide protein complexes to 
corresponding protospacers when the matched element is encountered again.  These 
complexes inactivate and/or degrade the targeted DNA or RNA, preventing infection or 
transfer of the element [5].  Because they integrate new spacers in the order in which they 
encounter various foreign elements, CRISPR arrays can be used to trace a chronological 
history of phage encounters in addition to recording the present immunity of each strain. 
To investigate CRISPR presence, diversity, and change over time in the vaginal 
microbiome, we used a network-based method to extract CRISPR repeat-spacer arrays 
from vaginal microbiome sequences of ten pregnant women during and after their 
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pregnancies.  We examined CRISPR diversity in each sample, as well as variation in 
CRISPRs between individuals and over the duration of pregnancy within each subject.  
We were able to identify CRISPRs in many microbial species and assess within-species 
CRISPR variation, enabling us to examine spacer variation within and between 
individuals. 
Results 
CRISPR presence is widespread in the vaginal microbiome 
At least one CRISPR repeat type was detected in 43 out of 53 samples analyzed; only one 
of the 10 subjects (201) lacked detectable CRISPR loci at all sampled time points (Figure 
3.1).  Interestingly, all CRISPR-less samples were obtained from subjects with a history 
of preterm birth.  CRISPR-containing reads were typically associated with the most 
abundant organisms in the sample, most frequently Lactobacillus iners, Lactobacillus 
crispatus, or Gardnerella vaginalis.  However, in samples from subjects 125 and 202, 
CRISPR reads were most frequently from Lactobacillus jensenii and G. vaginalis, while 
the samples were dominated by L. iners and Lactobacillus gasseri, respectively (Figure 
3.1). 
Spacer variation among individuals 
CRISPR repeat types were further subclassified into subtypes based on spacer content.  
Multiple instances of individuals harboring the same CRISPR repeat type with different 
spacer types were identified (Figure 3.2).  These occurrences were found in CRISPR loci 
from L. crispatus, G. vaginalis, and Anaerococcus lactolyticus.  In the case of L. 
crispatus, two CRISPR alleles emerged, each consisting of a single shared spacer and 
three unique spacers.  Allele 1A was present in two subjects, while 1B was found in 
three.  Seven unique spacers exist in the G.vaginalis type 3B locus, which appears in a 
single sample, while its other 16 spacers are present in Type 3A, present only in a 
different subject. The final case, A. lactolyticus, has three completely different sets of 
spacers, with none shared between them; each shows up in a single sample from a 
different subject. In all cases, no subject had multiple alleles simultaneously, nor did the 
allele present change over time (Figure 3.2). 
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Spacer variation over time within an individual 
Persistence of a repeat type over multiple time points in an individual was common; out 
of the nine subjects with CRISPR arrays identified, seven retained at least one repeat type 
for at least 3 consecutive samples (Figure 3.2).  Variation in the spacer content of these 
arrays, however, was less frequent.  Only one subject, 110, exhibited coexistence of 
multiple CRISPR alleles of the same repeat type.  Samples 110_1 and 110_2 contained 
three distinct L. iners CRISPR alleles, each distinguished by an additional leader-end 
spacer (Figure 3.3).  The same subject was also the sole example of change in spacer 
content over time.  After a period of undetectable L. iners CRISPRs in late pregnancy and 
labor, at 6 weeks postpartum, L. iners CRISPRs were again detectable, with a single 
CRISPR allele sharing many spacers of the most common allele present in early 
pregnancy, but with a novel leader-end spacer (Figure 3.3). 
Relationship between CRISPR variation and extrachromosomal elements 
To investigate whether changes in CRISPR type, abundance, or spacer content were 
correlated with changes in matched protospacers, we identified protospacer sequences 
matching all identified spacers in each sample (Figure 3.4). In sample 110_1, nine 
protospacers matched by L. iners spacers were present at high abundance; at subsequent 
time points, the abundance of the protospacers was substantially decreased or eliminated 
(Figure 3.4).  However, in other instances where both spacer and matched protospacer are 
present in the same subject, no apparent correlation exists between abundance of spacer 
and protospacer (Figure 3.4). 
Discussion 
Through bioinformatic analysis of a time series of samples from a cohort of pregnant 
women, we were able to identify CRISPR repeat-spacer arrays from a variety of 
organisms present in the vaginal microbiome.  While CRISPRs exist in a number of 
different species, with variation in spacer content between strains present in different 
individuals, we found remarkably limited diversity in spacer content within individuals, 
with limited evidence of coexistence of multiple CRISPR alleles or change in alleles over 
time.  We also found little correlation between spacer and matched protospacer presence 
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in the same sample; however, the primary examples of both within-patient CRISPR 
diversity and change in matched protospacer presence come from the same species in the 
same subject: L. iners from subject 110.  
CRISPRs are frequently among the most diverse parts of the genome, with extensive 
variation of CRISPR alleles found in metagenomes from acid mine drainage biofilms 
[31], Yersinia pestis isolates from Asian plague foci [9,25],  a collection of Streptococcus 
thermophilus strains [13], isolates from a single hot spring population of Sulfolobus 
islandicus [11,12], and the oral and gut microbiomes [23]. Modeling of CRISPR-
mediated host-virus interactions has also predicted the emergence and maintenance of 
CRISPR diversity [6,7].  Given this history of diversity, we anticipated finding variation 
within individual subjects, despite the previously observed limited species-level diversity 
of the vaginal microbiome, especially during pregnancy [1,26,32].  However, we only 
found multiple CRISPR alleles coexisting and changing over time in a single subject.  
This may indicate that these communities have low exposure to phages and other 
extrachromosomal elements, or that they interact with a limited pool of elements, such 
that most have already acquired spacers against most of the common elements.  The 
upheaval of the vaginal community associated with pregnancy may also significantly 
disturb the viral community, leading to an environment with limited phage pressure. This 
limited exposure would lower selection for strains which have added novel spacers, 
preventing them from increasing in frequency and becoming detectable in our 
metagenomic samples.  It is also possible that some of the many other mechanisms of 
resisting viral infection [15] predominate in these communities.   
Despite low diversity within individuals, heterogeneity between subjects was more 
common; of the three repeat types present in more than one individual, two had a 
different spacer set in each person; the third had two distinct alleles, with one or the other 
present in each subject.  This is consistent with broader examination of variation in the 
human microbiome, which finds highly personalized communities among individuals at 
multiple body sites [8]. However, despite this heterogeneity, in most cases where 
multiple subjects contain the same dominant species, no variation in CRISPR content is 
observed.  As with the lack of within-subject variation, this low diversity points to an 
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environment where either a limited pool of phage is encountered by these bacteria, or 
CRISPR immunity is not the preferred mechanism of evading viral infection. 
A previous examination of CRISPRs in 61 vaginal microbiomes of non-pregnant women 
[23] identified 4 known CRISPR repeat types, as well as a novel repeat.   The 21 different 
CRISPR repeats found by our analysis include three of these, all from Lactobacillus 
species, and a repeat type similar to Rho et al.’s A. lactolyticus repeat.  We did not 
identify the novel repeat type in our dataset. Rho et al. identified the three Lactobacillus 
repeats in roughly equal numbers of metagenomes (28, 31, and 33 out of 61); by contrast, 
we found that while two of the repeat types were found in 17 out of 53 samples, always 
co-occurring and from five different subjects, the other was found in only four samples, 
all from one subject.  These similarities and differences reinforce that while the vagina is 
generally colonized by a handful of common species, there can still be notable variance 
in community structure, especially when these communities undergo shifts as a result of 
significant events such as pregnancy. 
In addition to low levels of CRISPR variation, we also saw limited correlation between 
presence of CRISPR-matched elements and their cognate spacers.  Elements matched by 
spacers were found in every sample (Figure 3.4), indicating that these communities do 
encounter elements to which they have immunity; however, their abundance had little to 
do with presence or absence of matching spacers in the sample.  One notable change in 
matched element abundance was observed in subject 110.  Sequences matching nine 
spacers contained in L. iners CRISPR arrays were present at relatively high abundance in 
the first sample obtained; however, at later time points the abundance of these sequences 
drops sharply, in some cases becoming undetectable at this sequencing depth.  The even 
abundance of each of these protospacers implies that they may all be present in a single 
element, though they cannot be conclusively linked; as such, we may have captured the 
recent introduction or increase in abundance of a phage, plasmid or other element into 
this community.   Notably, a novel spacer was added to the L. iners CRISPR array in the 
final sample from this subject, taken six weeks postpartum.  This spacer appears at high 
abundance in the first sample and then decreases, undergoing identical dynamics to the 
nine previously described and implying this spacer may match the same element.  This is 
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consistent with an active L. iners CRISPR system adding a new spacer to a recently 
encountered element.  While the variation we detected in this dataset was limited, this 
observation shows that our method of identifying CRISPR array variants in metagenomic 
data using network analysis is sensitive enough to pick up CRISPR variants through time. 
Methods 
Sample collection 
Subjects were recruited from the patient population at the Mayo Clinic, Rochester, MN.  
Five subjects with a history of preterm birth (defined as at least one pregnancy resulting 
in preterm delivery) and five subjects with no history of preterm birth (defined as at least 
one successful pregnancy, and no pregnancies ending in preterm delivery) were selected.  
All subjects were Caucasian and had resided in Rochester for a minimum of 23 years.  
Consent to sample collection was obtained from each patient at each collection time. 
Swabs were collected from the posterior fornix of each subject at up to six time points: 
gestational week 8-12, 17-21, 26-30, 35-38, labor, and six weeks postpartum (Table 3.1).   
Sequencing, processing and taxonomic assignment 
DNA was extracted from each sample, and Illumina HiSeq DNA sequencing was 
performed, producing 100 bp paired end reads.  Quality filtered sequence data cleaned of 
human DNA contamination was kindly provided by Fang Yang and Bryan White of the 
Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-
Champaign. Sequences shorter than 50 bp or with an average quality score below 20 
were discarded.  Reads were assigned to species via blastn (e=1e-5) against the Human 
Microbiome Project urogenital reference database (downloaded Nov. 15, 2013). 
CRISPR identification via network analysis 
Potential CRISPR repeat sequences in each sample were identified using CRASS [27].  
Potential repeats were compared via blastn [2] to the NCBI nt database; any sequences 
which primarily hit non-microbial sequences were classified as false positives and 
excluded from further analysis.  Reads matching remaining potential CRISPR repeats or 
a list of known Lactobacillus CRISPR repeats were identified using blastn (blastn-short, 
66 
 
e<=0.1, >=90% nucleotide identity) . To establish spacer order and detect even rare 
coexisting CRISPR alleles, spacers were linked as follows: 12-nucleotide “chunks” of 
DNA flanking each repeat were identified using fuzznuc [24]; up to 8 mismatches to the 
repeat sequence were allowed to capture degenerate repeats.  Due to the palindromic 
nature of the repeats, this occasionally generated situations where the repeat was matched 
in both orientations; in these cases, the match with fewer mismatches was kept and the 
secondary match discarded.  Chunks that were a perfect match to the repeat sequence 
(i.e., from two adjacent repeats or partial repeats) were also discarded.  Finally, singleton 
chunks that perfectly overlap non-singleton chunks by at least 8 bp were removed, to 
account for rare chunks generated by sequencing error.   
Custom bash scripts were used to identify occurrences of two or more chunks on the 
same read. These were recorded as links, which represent either two ends of the same 
spacer, or opposite ends of two spacers linked across a repeat.  The first type of link was 
used to identify spacer sequences; the second, to order spacers and identify branch points, 
i.e. where multiple alleles with partially shared spacer content exist.  Linkage networks 
were analyzed using Cytoscape [28].  Based on average repeat and spacer lengths of 
species known to inhabit the vagina, links spanning 60 bp or less were considered short 
links, spanning only a single spacer or pair of adjacent spacers; longer links were 
considered to span multiple spacers and were not counted when determining coverage of 
links across a spacer or between adjacent spacers. 
All sequences flanked by repeats on both sides were considered potential spacers and 
were extracted.  All spacers identified using the same repeat were considered a repeat 
type, denoted by a number; variant alleles within a repeat type were designated by adding 
a letter to their group number (i.e. 2A, 2B, etc.). 
Identification of matched protospacers 
To determine presence and abundance of protospacer-containing elements matched by 
our spacer library, we used blastn (blastn_short e<=0.1, >=90% nucleotide identity) to 
compare all identified spacers from all samples to a database of all metagenome reads.  
Reads previously used to build CRISPR arrays were excluded from analysis. 
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Figures and Tables 
 
Figure 3.1. Species abundance and CRISPR presence in the vaginal microbiome.  Black 
circles represent the proportion of reads from each sample which correspond to the species; 
colored circles represent the number of reads matching CRISPR loci per spacer per million reads.  
Black lines separate individual subjects, while the red line separates low-risk subjects (above) 
from high-risk subjects (below). 
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Figure 3.1. (cont.) 
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Figure 3.2. Spacer variation among subjects.  Colored circles represent the number of reads 
matching each CRISPR locus type per spacer per million reads.  The red line separates low-risk 
subjects (above) from high-risk subjects (below).  Colors are consistent with those in Figure 3.1. 
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Figure 3.3. Spacer variation over time in the L. iners population of subject 110. Each line 
represents a repeat-spacer array found at the listed time point.  Gray bars are repeats, blue bars are 
spacers shared between all alleles, and other colors represent spacers not present in all alleles. 
The leader end of the array is to the left. PP, postpartum.  
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Figure 3.4. Spacer hits in the vaginal microbiome.  Open triangles represent the number of 
BLAST hits from each spacer to the non-CRISPR portion of each sample, while colored circles 
represent the abundance of each spacer in the CRISPR loci of the sample an in Figure 3.2.  Black 
lines separate individual subjects, while the red line separates low-risk subjects (above) from 
high-risk subjects (below). 
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Figure 3.4. (cont.) 
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Table 3.1. Subjects and samples used in the study.  PP: 6 weeks postpartum. 
Subject 
ID 
Preterm Risk 
Level 
Samples  Subject 
ID 
Preterm Risk 
Level 
Samples  
110 Low 8-12 wks 
17-21 wks 
26-30 wks 
25-38 wks 
Labor 
PP 
201 High 8-12 wks 
17-21 wks 
26-30 wks 
Labor 
117 Low 8-12 wks 
17-21 wks 
26-30 wks 
25-38 wks 
Labor 
PP 
202 High 8-12 wks 
17-21 wks 
26-30 wks 
25-38 wks 
PP 
119 Low 8-12 wks 
17-21 wks 
26-30 wks 
25-38 wks 
PP 
203 High 8-12 wks 
17-21 wks 
26-30 wks 
25-38 wks 
Labor 
PP 
120 Low 8-12 wks 
17-21 wks 
26-30 wks 
25-38 wks 
PP 
205 High 8-12 wks 
17-21 wks 
26-30 wks 
Labor 
PP 
125 Low 8-12 wks 
17-21 wks 
26-30 wks 
25-38 wks 
PP 
206 High 8-12 wks 
17-21 wks 
26-30 wks 
25-38 wks 
Labor 
PP 
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CHAPTER 4 
 Detection of CRISPR Spacers in Metagenomes from the Cystic Fibrosis Lung 
Abstract 
Viruses can have dramatic impacts on microbial communities, and in the human 
microbiome, virus-microbe interactions can influence the health of the human host. The 
microbial community of the cystic fibrosis lung plays a critical role in the clinical 
outcome of the disease, and Pseudomonas aeruginosa infection in particular is 
responsible for much of the morbidity and mortality associated with this condition. The 
CRISPR immune system is an important mechanism by which microbes gain immunity 
to viruses, and diversity of spacer content may affect population stability. To better 
understand how CRISPR diversity influences how P. aeruginosa and other bacteria 
interact with phages, we sequenced bacterial and viral metagenomes from sputum and 
explant lung samples from 12 cystic fibrosis patients and identified CRISPR sequences in 
a focal subset of samples.  We found highly varied P. aeruginosa spacer content between 
patients, but no evidence of within-patient diversity despite deep sequencing.  Many of 
the identified spacers matched known phages or other foreign genetic elements; however, 
few of these elements were found in the samples containing hosts with matching spacers.  
These findings raise questions about the phage-host interactions in the cystic fibrosis lung 
and open the door to future investigation of other bacteria which colonize this 
environment. 
Introduction 
The microbial communities which comprise the human microbiome are no exception to 
the effects of microbe-virus interactions. Viruses have been observed all over the human 
body, and viral communities have been studied in the oral cavity, on the skin, in the 
bloodstream, in the respiratory tract, and in the gut [1]. Direct effects on microbial 
communities by phage have also been observed; in a gnotobiotic mouse model of the 
human gut microbiota, the gut community was subjected to a phage attack, resulting in 
shifts in microbial community dynamics [21].  
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Among the many human-associated microbial communities which impact human health 
and disease is the community of the cystic fibrosis lung.  Cystic fibrosis is among the 
most common life-shortening human genetic disorders, particularly in those of northern 
European descent, among whom the disease is present in 1 in 3,000 live births [20].  
While the disease is genetic in origin, the vast majority of morbidity and mortality stems 
from persistent microbial infections in the lung [6].  Among the most common and 
damaging of these pathogens is Pseudomonas aeruginosa, which plays a key role in 
cystic fibrosis morbidity and mortality [13].  P. aeruginosa is a ubiquitous opportunistic 
pathogen, and cystic fibrosis patients are believed to primarily be colonized by strains 
encountered in their environment, which subsequently adapt to the lung environment and 
thrive [13].  Once established, P. aeruginosa infections are difficult to eradicate, owing to 
biofilm formation and widespread antibiotic resistance [7].   
The CRISPR adaptive immune system is one method by which microbial hosts can gain 
immunity to viruses, and CRISPRs could have significant impacts in microbial 
communities on multiple levels.  Their ability to target many types of foreign and mobile 
genetic elements contributes to viral resistance while also restricting horizontal gene 
transfer, leading to a tradeoff between the potential benefits of introducing new genes and 
protection against viral lysis or other negative consequences.  Though some systems have 
been found to strike a balance by tolerating temperate phage integration while preventing 
lytic induction [10], in many other cases, active CRISPR systems prevent any 
maintenance of the matched element in the cell [3,8,18].   As a result of their ability to 
add a wide array of potential spacers to any given element, CRISPR arrays are among the 
most diverse regions of the microbial genome. Diversity of spacer content may also have 
an effect on population stability through distribution of immunity; simulated populations 
with varied spacers to a similar phage pool were found to be more stable, with 
corresponding viral populations more prone to extinction [5].   
To investigate diversity in the CRISPR system of the microbes which inhabit the cystic 
fibrosis lung, we sequenced bacterial and viral metagenomes from cystic fibrosis sputum 
and lung explant samples and identified CRISPR alleles from all possible species.  P. 
aeruginosa was chosen as a representative species to describe its CRISPR diversity, 
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spacer targets, and the dynamics of protospacer-containing elements in matched viral 
metagenomes.   
Results 
Bacterial species presence and abundance varies among cystic fibrosis patients 
For our initial screen, 10 total sputum samples were obtained from five patients at one to 
three time points (Figure 4.1) and sequenced.  Taxonomic classification of the resulting 
reads revealed major differences in the composition of these communities (Figure 4.2).  
Samples were clearly divided into two major categories by the dominant organism. 
Patients CF15 and CF16 were dominated by Rothia mucilaginosa, a common resident of 
the human oral cavity and upper respiratory tract which can become an opportunistic 
pathogen  in cystic fibrosis patients [17].  Samples CF15B and CF16A were most 
strongly dominated by R. mucilaginosa, with over 80% of reads in each sample coming 
from this organism.  Sample CF16B was 56% R. mucilaginosa, with an additional 28% 
of the reads belonging to Enterococcus faecalis, a species not found in any of our other 
four patients.  Sample CF15A was the richest and most even of the samples analyzed; 
while dominated by R. mucilaginosa at 25% of reads, it contained two other species 
making up 10% or more of the total read abundance: Streptococcus parasanguinis (14%), 
P. aeruginosa (11%), as well as numerous other species making up smaller proportions 
of the community. 
By contrast, patients CF14, CF17, and CF19 were dominated by Staphylococcus aureus, 
often one of the first pathogens to colonize the lungs of children with cystic fibrosis [11].  
All but one of the six samples from these patients was dominated by S. aureus, with a 
relative abundance of 60% and even reaching as high as 94% in one sample, with the 
remaining reads largely belonging to Streptococcus and Rothia species.  The sole 
exception is sample CF14C, which contained only 10% S. aureus and was instead 
dominated by Escherichia (56% E. coli and 14% Escherichia reads which could not be 
classified at the species level). 
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Identification of CRISPR spacers in metagenomes 
We next conducted a broad survey of CRISPRs present in all species in these 
metagenomes.  To capture the maximum number of spacers possible, even those without 
known repeat sequences, we used a pipeline including Crass [27], a program capable of 
detecting CRISPR-like sequences de novo in metagenomic sequence reads, to identify 
potential CRISPR loci in these metagenomes (see Methods for details).  We chose to 
focus on patients CF15A and CF16A, as the others were strongly dominated by S. 
aureus, which rarely harbors CRISPR loci [12].  Specifically, we chose samples CF15A 
and CF16A for their relative species-level diversity, and because many of the species 
present were known to contain CRISPRs [12].  We identified 17 CRISPR repeats in 
sample CF15A and four in the less diverse CF16A, for a total of 20 unique repeats 
(Figure 4.3).  In CF15A, the most prevalent repeat matches a repeat found in Rothia 
genomes; however, despite the fact that both samples are dominated by Rothia, we failed 
to identify any Rothia-linked repeats in sample CF16A.  This could be the result of 
different strains of Rothia residing in these two patients, only one of which contains a 
CRISPR system. In keeping with CF15A having a greater species richness, it contains far 
more different repeat types belonging to different species than CF16A.  In fact, the only 
repeat type shared between these two samples is one belonging to P. aeruginosa. 
P. aeruginosa CRISPRs lack coexisting diversity in metagenome samples 
Given the presence of P. aeruginosa CRISPR repeats in both of our focal samples, and 
the status of the species as an important cystic fibrosis pathogen, we chose to investigate 
the spacer content and diversity of P. aeruginosa CRISPRs in these two metagenomes in 
more detail.  We used a network analysis-based method (see Methods) to identify repeat-
spacer arrays as well as variant loci.  P. aeruginosa strains typically possess Type I 
CRISPR loci, most commonly of subtype I-F and less frequently of subtype I-E; both 
types may be present in the same strain, and can be differentiated by repeat sequence or 
types of cas genes present [4].  We observed two repeat-spacer arrays in each of these 
samples with repeat sequences associated with Type I-F CRISPRs, containing 12 to 18 
spacers each, with no evidence of variant alleles (Figure 4.4).  P. aeruginosa CRISPR 
systems commonly contain two repeat-spacer arrays with very similar repeats, so while 
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the two arrays cannot be conclusively linked to each other, it is likely they represent two 
parts of a single CRISPR system, so the lack of variation observed indicates a single 
CRISPR-type is present in each sample.  The arrays from the two samples are completely 
distinct, sharing no spacers with one another. 
To broaden our sample size of P. aeruginosa CRISPRs, we also identified CRISPRs in 
sample CF15B, the only other sample with detectable P. aeruginosa; however, coverage 
was not sufficient to fully assemble CRISPR loci, and all identified spacers were also 
present in CF15A, leading us to conclude that CF15B contains the same CRISPR-type as 
CF15A (Figure 4.4).  We also sequenced metagenomes of four additional samples:  two 
sputum samples from consecutive days from a longitudinal study of a single cystic 
fibrosis patient, and two samples from a cystic fibrosis lung explant (Figure 4.1).  Despite 
all samples being high in P. aeruginosa (Figure 4.2), we again found two Type I-F 
arrays, with no variation in the explant samples; the same pair of arrays was found in 
both samples. In addition, we found two additional shorter arrays with a different repeat 
type associated with Type I-E CRISPRs (Figure 4.4).  As before, all the spacers in these 
arrays were unique and not found in the other samples. In the longitudinal samples, no 
evidence of P. aeruginosa CRISPRs was found. 
Identified CRISPRs are similar to previously sequenced CRISPRs 
To determine if the CRISPR loci extracted from our metagenomes were related to those 
from any previously sequenced P. aeruginosa strains, we compared all of our identified 
spacers to the NCBI nt database using blastn.  We found that the CF15A CRISPR-type 
shared all of its spacers with the small colony variant isolate SCV20265, isolated from a 
cystic fibrosis patient in Hannover, Germany, though the SCV strain had two additional 
spacers in one array that did not appear in our metagenomes (Figure 4.5). The CF16A 
arrays were identical to those found in SMC4501, a sputum isolate from 1999 in 
Hanover, New Hampshire (Figure 4.5).  The explant strain held CRISPRs substantially 
similar to those in SMC4489, a P. aeruginosa strain isolated from an eye infection in 
Pittsburgh, Pennsylvania in 1994; all of the Type I-F and I-E spacers we found were 
present in the eye isolate; however, that isolate had an additional Type I-E array 
containing spacers not found in our metagenome samples (Figure 4.5).  
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Identification of matched protospacer sequences 
Spacers identified in the three metagenomic samples were blasted against the NCBI nt 
database to identify known viruses, plasmids, or other elements they matched.  In 
CF15A, 15/30 spacers (50%) matched a known phage, prophage, plasmid, or genomic 
island (Figure 4.6).  By contrast, only 7/28 spacers (25%) found in sample CF16A had 
known matches; intriguingly, one of the two arrays contained no spacers with known 
matches (Figure 4.6).  In the Type I-F arrays of the explant samples, 17/30 spacers (57%) 
matched known elements; the Type I-E arrays had 8/11 spacers (73%) with matches 
(Figure 4.6).  Most spacers (34) matched known phages, with smaller numbers matching 
plasmids (3) and non-phage genomic islands (7).  Sixteen also matched prophage 
characterized in the Liverpool epidemic strain LESB58 of P. aeruginosa.   Strikingly, 
every spacer with a known match in the Type I-E arrays found in explant samples 
matched three such prophage, while in the Type I-F systems of all three samples, only 
two to three spacers matched these prophage (Figure 4.6). 
Protospacer presence in host and viral metagenomes 
To determine if any of the elements matched by our identified spacers were present in the 
corresponding sample, we used blastn to compare the spacers to both the host 
metagenomes (excluding reads identified as being part of CRISPR loci) and matched 
viral metagenomes for samples CF15A and CF16A (a matched viral sample was 
unavailable for the explant samples).  We found two spacers from CF15A matched 
protospacers in the CF15A viral metagenome; one matching phiCTX and one matching 
phages D3, phi297, and vB_PaeS_PMG.  In the host metagenome, we found four 
matched protospacers at modest to low coverage: the same D3-matching spacer observed 
in the viral metagenome, plus spacers matching the pathogenicity island PAPI-1 and 
phages JBD18 and D3112 (Figures 4.6 & 4.7).   In the CF16A viral metagenome, we 
found five matched protospacers, all at relatively low abundance:  one spacer matching 
the genomic island PAGI-6, one matching phage F10, one matching many phage 
including DMS3,  D3112, and LES prophage 4, and two matching no known phages, 
plasmids, or genomic islands.  In the host metagenome, we found three low-abundance 
protospacers, two of which had no known matches and one of which matches phages D3 
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and vB_PaeS_PMG.  None of these overlap with the spacers found in the viral sample, 
and all are at a lower relative abundance than the average spacer (Figures 4.6 & 4.7).    
In contrast to the general low number of matches and low abundance in the matched 
metagenomes, we found a protospacer at higher abundance in our CF15A host and viral 
metagenomes which was matched by a CF16A protospacer (Figure 4.7).  This spacer, 
which also appears in the CF16A viral metagenome at a much lower relative abundance, 
matches several phages, including DMS3, D3112, and LES prophage 4 (Figure 4.6).  
This was by far the most abundant protospacer identified, whether in sample from the 
same patient or across samples. 
Discussion 
In our investigation of CRISPR diversity in the cystic fibrosis lung metagenome, we 
found an abundance of CRISPR-containing species, including the critical cystic fibrosis 
pathogen P. aeruginosa. In samples from three patients, we found completely non-shared 
CRISPR spacers, highlighting the diversity of spacers among P. aeruginosa strains; 
however, each of these CRISPR-types was substantially similar to a previously 
sequenced strain from distant locations, showing that related strains have migrated 
globally. Despite the variation between patients, we observed no CRISPR diversity 
within any of the patients.  The spacers we observed in these three distinct CRISPR-types 
match many known phages and prophages as well as some plasmids and genomic islands, 
but over half of the spacers we found match no known elements.  Few protospacers 
matched by these spacers are present in the same host metagenome, or in matched viral 
samples, though we do detect matching protospacers in other metagenomes. These 
findings reveal low levels of intra-patient diversity coupled to a globally-distributed, 
diverse P. aeruginosa population and incite further investigation into CRISPR diversity 
in P. aeruginosa and other species in the cystic fibrosis lung environment. 
At the outset of this study, we hypothesized there would be coexisting CRISPR spacer 
alleles within a single patient at the same time point based on previous work showing that 
diverse immunity encourages microbial population stability by preventing viruses from 
evading all host immunity through a single escape mutation [5].  However, our close 
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investigation of P. aeruginosa CRISPRs revealed that this was not the case.  Why might 
the cystic fibrosis lung environment not foster local diversity in P. aeruginosa CRISPRs?  
It is possible that P. aeruginosa does not experience significant phage pressure in this 
environment, which would both limit its ability to diversify (by restricting the pool of 
elements from which the CRISPR system can acquire new spacers) and remove the 
fitness advantage the host microbe gains from such diversity.  However, lytic P. 
aeruginosa phage activity has been shown in chronic cystic fibrosis lung infections [14]. 
Though this study only investigated a specific subset of temperate phages present in LES 
strains and may not be reflective of the dynamics of other P. aeruginosa phage, it is still 
clear that phages play an important role in cystic fibrosis lung ecology. It is also possible 
that P. aeruginosa is employing other resistance mechanisms to deter phage, making 
CRISPR diversity less advantageous.  Further sampling of cystic fibrosis patients is 
needed to determine if this lack of diversity is generally representative of P. aeruginosa 
in the cystic fibrosis lung. 
Despite the lack of diversity within each patient, we observed completely different spacer 
arrays between patients, each of which was substantially similar to CRISPRs in other P. 
aeruginosa strains. These strains came from geographically distant sites and from 
different body sites – only one was from a cystic fibrosis patient.  This observation 
indicates a ubiquitous P. aeruginosa population where strains can colonize varied 
environments, rather than separating into more specific niches.  This is consistent with 
previous observations of a common P. aeruginosa clone type, clone C, in aquatic 
environments, cystic fibrosis clinics, and cystic fibrosis patients [23,24].  Other studies 
have also identified the environment rather than other patients as the primary source for 
acquisition in patients [29] and found that cystic fibrosis isolates are a random subset of 
the larger environmental population [15].  While certain transmissible strains such as 
Liverpool, Manchester, and Australian epidemic strains have adapted to infect the CF 
lung [9], the strains we found in these three patients appear to be part of a globally 
distributed population of P. aeruginosa which can move between environments. 
Among our three identified CRISPR-types, we found spacers matching three integrated 
LES prophage in every array, save for one in CF16A.  In the Type I-E arrays of the 
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explant samples, seven out of eleven spacers matched these prophages.  The LES 
prophage have previously been found to confer a competitive advantage in a rat chronic 
lung infection model [32], and have been shown to exist as free phage with lytic activity 
in the human cystic fibrosis lung [14].  These data support a role for such prophage in 
competition between P. aeruginosa strains in the lung; our observation of numerous 
spacers matching these prophages shows that these strains have encountered these 
prophage or their close relatives repeatedly through time.  Due to the Type I CRISPR 
system’s protospacer adjacent motif (PAM)-based self-recognition system [19], any host 
with an active Type I system and one or more spacers matching a phage cannot integrate 
that phage into its genome; its Cas machinery will target the integrated prophage, leading 
to destruction of its own DNA.  Therefore, possessing these spacers prevents the strains 
we found from incorporating these advantageous prophages, unless the CRISPR system 
has been inactivated.  Consistent with this, we found that while the CF15A and CF16A 
strains both had spacers matching LES prophage, few to no reads containing those 
protospacers were found in their respective host metagenome.  One LES protospacer 
matched by CF16A was found at higher abundance in the CF15A host metagenome 
sample, which lacks that spacer; however, that protospacer sequence is conserved in eight 
related sequenced phage (see Figure 4.6), and thus is not necessarily indicative of LES 
phage presence.  Such a tradeoff reflects a delicate balance between the safety of 
CRISPR immunity to phages and other elements and the potential advantages these 
elements can bring, such as antibiotic resistance or pathogenicity islands.  These strains 
appear to have taken the safe route, maintaining their ability to fight of invasions by LES 
strains; a comparison of their fitness to strains with missing or nonfunctional CRISPRs 
would be informative and may help further elucidate these tradeoffs. 
While little diversity was observed in P. aeruginosa CRISPRs, there remains 
considerable untapped data in these metagenomes. In our preliminary scan of this data, 
we found 19 other CRISPR repeat types found in our two focal samples, and we 
anticipate finding even more in the remainder of these samples, especially those with 
different compositions.  These repeats belong to at least 15 different genera, each with the 
potential to have its own level of CRISPR variation and distinct pattern of interactions 
with phage.  Some of these genera are deeply covered in the sequence data; for example, 
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over 2,300 reads contain the Rothia repeat found in sample CF15A. Such samples offer 
great promise for identifying CRISPR diversity if it exists in these samples, as deeper 
coverage enables easier detection of rarer CRISPR variants. The potential to uncover 
more information about CRISPR diversity in the cystic fibrosis lung is vast, and 
investigating these additional taxa remains a promising area for future study. 
Methods 
Sample selection and processing 
Samples were collected and processed by Douglas Conrad of the University of California 
San Diego and Yan Wei Lim of San Diego State University, with assistance from other 
members of the Forest Rohwer lab at San Diego State University. All samples were 
obtained from adult male cystic fibrosis patients at the University of California San 
Diego Adult Cystic Fibrosis Clinic, La Jolla, CA, during regular clinic visits, in 
accordance with the University of California and San Diego State University institutional 
review boards. Sample collection, processing, and DNA extraction were performed as in 
[16]. Briefly, induced sputum samples were collected following an inhalation of saline 
solution and an oral rinse to minimize contamination from oral microbiota.  Samples 
were homogenized and aliquoted for separate protocols for bacterial and viral 
metagenome sequencing.  Bacterial metagenome samples were treated with beta-
mercaptoethanol to disrupt mucus, repeatedly washed to induce hypotonic lysis of human 
cells, and treated with DNase to remove DNA from lysed cells as well as extracellular 
microbial DNA from biofilm formation.  Viral samples were treated with dithiothreitol to 
disrupt mucus, filtered, and subjected to CsCl gradient ultracentrifugation to isolate viral 
particles.  DNA was extracted from both sample types, via CTAB/phenol-chloroform 
extraction for the viral samples and NucleoSpin tissue kit for bacterial samples.  Lung 
explant samples were collected and processed as described in [31].  Briefly, the interior 
surface was cut from 2 cm x 4 cm lung tissue samples and homogenized before DNA 
extraction using a NucleoSpin tissue kit. 
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Metagenome sequencing 
All bacterial and viral metagenomes were prepared and sequenced by the Roy J. Carver 
Biotechnology Center at the University of Illinois. Libraries were prepared using TruSeq 
Sample Prep kits (Illumina, San Diego, CA).  Bacterial samples from patients CF14, 
CF15, CF16, CF17, and CF19 were each sequenced using a full lane on an Illumina 
MiSeq v2 sequencer (Illumina, San Diego, CA), producing 250 nt paired-end reads. Focal 
bacterial samples CF15A and CF16A were additionally sequenced using a full lane per 
sample on an Illumina HiSeq2500 (Illumina, San Diego, CA), producing 160 nt paired-
end reads.  Viral samples CF15A and CF16A were each sequenced using a full lane of 
Illumina MiSeq, as with the bacterial samples. Explant and longitudinal samples were 
sequenced using an Illumina HiSeq2500.  One sample, Explant C, received a full lane of 
sequencing, while the remaining explant sample and two longitudinal samples were 
barcoded and pooled in a second lane.  Sequencing adapters were trimmed from the 
resulting reads by the sequencing center. 
Quality filtering and human sequence removal 
All sequenced samples were quality filtered using Prinseq 0.20.4 [26]. Reads were 
dereplicated to eliminate PCR duplicates and trimmed from the left and right ends using a 
5nt sliding window with a minimum quality score of 30.  Reads were retained if they had 
a mean quality score of 30 and less than 1% ambiguous bases. The minimum read length 
was set to approximately two-thirds the anticipated read length, resulting in a cutoff of 
100 nt for HiSeq data and 160 nt for MiSeq data.  After quality filtering, contaminating 
human sequence was removed using DeconSeq [25]; reads matching databases of 
bacterial or viral sequences and those matching no databases were retained, while those 
matching human sequence databases were removed. 
Estimation of relative abundance 
In all bacterial samples, relative abundance of taxa was calculated using MetaPhlAn2 
[30], which classifies reads using clade-specific marker genes from 17,000 reference 
genomes to provide a species-level estimate of relative abundance.  Default parameters 
were used. 
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CRISPR identification 
For focal samples CF15A and CF16A, potential CRISPR repeat sequences in each 
sample were identified using CRASS [27].  Potential repeats were compared via blastn 
[2] to the NCBI nt database; any sequences that primarily hit non-microbial sequences 
were classified as false positives and excluded from further analysis.  Reads matching 
remaining potential CRISPR repeats were identified using blastn [2] (blastn-short, 
e<=0.1, >=90% nucleotide identity). To establish spacer order and detect coexisting 
CRISPR alleles, spacers were linked as follows: 12-nucleotide “chunks” of DNA 
flanking each repeat were identified using fuzznuc [22]; up to 8 mismatches to the repeat 
sequence were allowed to capture degenerate repeats.  Due to the palindromic nature of 
the repeats, this occasionally generated situations where the repeat was matched in both 
orientations; in these cases, the match with fewer mismatches was kept and the secondary 
match discarded.  Chunks that were a perfect match to the repeat sequence (i.e., from two 
adjacent repeats or partial repeats) were also discarded.  Finally, singleton chunks that 
perfectly overlap non-singleton chunks by at least 8 bp were removed, to account for rare 
chunks generated by sequencing error.   
Custom bash scripts were used to identify occurrences of two or more chunks on the 
same read. These were recorded as links, which represent either two ends of the same 
spacer, or opposite ends of two spacers linked across a repeat.  The first type of link was 
used to identify spacer sequences; the second, to order spacers and identify branch points, 
i.e. where multiple alleles with partially shared spacer content exist.  Linkage networks 
were analyzed using Cytoscape [28].  Based on average repeat and spacer lengths of 
species with previously sequenced CRISPR loci, links spanning a single repeat-spacer 
unit were considered short links, spanning only a single spacer or pair of adjacent 
spacers; longer links were considered to span multiple spacers and were not counted 
when determining coverage of links across a spacer or between adjacent spacers. 
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Comparison of identified spacers to sequenced P. aeruginosa and extrachromosomal 
element sequences 
All spacers from our three identified CRISPR-types were blasted against the NCBI nt 
database using blastn (blast-short, e= 0.1).  For matches to other CRISPR arrays, only 
full-length perfect matches to P. aeruginosa strains were considered, and regions 
flanking the hits were examined to ensure they contained CRISPR repeat sequence.  For 
matches to phages and plasmids, matches with an e-value below 0.1 and at least 90% 
coverage of the query were retained. 
Identification of matched protospacers in metagenomes 
All spacers identified in CF15A and CF16A were compared to local blast databases of 
reads from host and viral metagenomes from those samples using blastn (blastn-short, 
e=0.1).  Reads previously identified as containing CRISPR repeats were excluded from 
analysis.  The number of hits was normalized by the number of reads in the database. 
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Figures   
 
 
 
 
 
 
 
Figure 4.1.  Samples used in this study.  The upper bar represents the patient; the lower boxes 
represent individual samples taken at different times (CFxx & Longitudinal) or in different areas 
of the lung (Explant). Samples shaded in tan have host metagenome sequences; those with bold 
dotted outlines additionally have matched viral metagenomes sequenced.   
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Figure 4.2.  Heatmap of taxonomic classifications of metagenome reads. Reads were assigned 
to species-level taxa using MetaPhlAn [30].  Colors indicate higher or lower abundance of 
species in accordance with the scale at the top of the figure; black boxes represent absent taxa.  
Species are grouped vertically per the tree to the left; samples are grouped horizontally by shared 
taxa as shown by the tree at the top of the figure. 
  
92 
 
 
 
 
 
 
 
 
Figure 4.3.  CRISPR repeats identified in two metagenomes. Each circle represents a repeat 
type.  Area of the dot is scaled to the number of reads containing the repeat, normalized to the 
number of spacers in the repeat-spacer array and the number of reads in the sample.  Repeat types 
are assigned to the most likely organism at the genus level based on repeats identified in 
publically available sequence data [12]. 
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Figure 4.4.  P. aeruginosa repeat spacer arrays identified in metagenomes. Each 
numbered block is a spacer; each contiguous block of spacers represents an individual 
array. Arrays of the same type from the same sample are grouped horizontally. 
  
CF16A – Type I-F 
 
CF15A and CF15B – Type I-F 
Explant C & H – Type I-F 
 
Longitudinal Days 4 & 5 – No CRISPRs 
Explant C & H – Type I-E 
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Figure 4.5.  P. aeruginosa from San Diego cystic fibrosis patients have similar 
CRISPRs to globally distributed strains. Each colored circle represents a CRISPR-type 
identified from our metagenomes or from publicly available sequence data. Color-
matched circles share all or most of their spacers.  Sampling date and body site are shown 
for each sample. 
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CHAPTER 5 
CRISPR Surveillance of a Panmictic Global Population of Pseudomonas aeruginosa 
Phage via a Novel Prototyping Method 
Abstract 
The demographics of the human virome remain elusive to the high-throughput molecular 
examination that is the mainstay of microbial ecology.  Here we develop the sequence-
specific CRISPR adaptive immune system as a surveillance tool to track virus 
demographics within and between microbial populations associated with the 
opportunistic human pathogen P. aeruginosa.  We find that CRISPR spacers match the 
majority of known sequenced P. aeruginosa phages, as well as predicted prophage in 
well-characterized strains.  We use these spacers to identify specific sequence tags that 
can be used to recognize and track phage populations in a high-resolution, high-
throughput way.  We use the distribution of these sequence tags to show that P. 
aeruginosa and its phages are globally distributed and highly mobile between the human 
and environmental spheres.  The abundance of sequence signatures matching particular 
phage groups demonstrates the abundance of interactions between this group and the 
diversity of P. aeruginosa strains that inhabit all environments.  Application of this large 
library of spacers as a surveillance tool to track phage elements can be used beyond 
CRISPR typing to follow phage dynamics independent of their hosts with important 
implications for tracking virulence islands and antibiotic resistance, as well as making 
personalized predictions for phage therapy in this potent human pathogen. 
Introduction 
Viral infection is known to have considerable impact on the evolution of microbial 
communities in all environments including the human microbiome [3,42,48,49,50].  
Among the many human body sites where the microbial community can impact health is 
the cystic fibrosis lung.  Cystic fibrosis is among the most common life-shortening 
human genetic disorders, and while the disease is genetic in origin, the vast majority of 
morbidity and mortality stems from persistent microbial infections in the lung [19]. 
Among the most widespread and damaging of these pathogens is Pseudomonas 
aeruginosa, which plays a key role in cystic fibrosis morbidity and mortality [28].  P. 
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aeruginosa is a ubiquitous opportunistic pathogen, and cystic fibrosis patients are 
believed to primarily be colonized by strains encountered in their environment, which 
subsequently adapt to the lung environment and thrive [28].  Eradicating an established 
P. aeruginosa infection via antibiotic therapy can be difficult to impossible, leading to 
consideration of phage therapy as an alternative treatment method.  Numerous studies 
have shown the therapeutic promise in vitro and in vivo in animal models [46].  For 
phages to become a safe and effective treatment strategy, understanding their potential 
interactions with P. aeruginosa is a critical step. 
Comparisons of even small numbers of P. aeruginosa genomes has revealed a dynamic 
variable genome replete with horizontally transferred elements, many of which are 
prophages and phage-like elements [35,41].  This variable genome can occupy 10% of 
the otherwise highly conserved P. aeruginosa genome and contains genes which this 
pathogen can use to maintain its presence in the human body, including virulence factors 
and antibiotic resistance genes [37].  Phages represent a major pathway for the transfer of 
these critical genes; for example, the temperate cytotoxin-converting phage phiCTX 
encodes a toxin shown to increase P. aeruginosa virulence in a mouse model [4].  Other 
prophages have affected varying functions important for colonization and persistence, 
including cell adhesion, resistance to phagocytosis, and exopolysaccharide digestion for 
biofilm remodeling [37].  Notably, prophage also play an important role in the Liverpool 
epidemic strains (LES), which are responsible for 10% of cystic fibrosis-associated 
infections in the United Kingdom [39].  These strains are adept at colonizing the lung, 
display increased antibiotic resistance, and are associated with worse clinical outcomes 
[25].  Some of the colonization advantages of the LES strains have been shown to lie in 
integrated prophage in the LES genome. These elements contain genes homologous to 
phages D3, D3112, F10, and Pf1, and disrupting three of these prophage has been show 
to put the strain at a competitive disadvantage relative to its wild-type ancestor in a rat 
lung chronic infection model [61].  Some of these integrated phages have also been 
shown to retain their lytic activity and may affect P. aeruginosa density in chronic cystic 
fibrosis lung infections [30]. 
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Tracking elements such as phages, which can significantly impact longevity, virulence, 
and persistence of their bacterial hosts, has great impacts on understanding human 
disease dynamics.  However, because phages are highly modular, diverse and represent a 
relatively small portion of the DNA in any environment, investigating their ecology using 
molecular tools is difficult.  Luckily, P. aeruginosa employs the CRISPR-cas immune 
system as its own mechanism for surveillance of mobile elements.  The CRISPR system 
consists of arrays of alternating palindromic repeats interspersed with short DNA 
fragments called spacers and a series of CRISPR-associated (cas) genes.  CRISPR 
spacers frequently match segments (protospacers) of mobile genetic elements such as 
viruses, plasmids, and transposons [43].  Upon encountering a foreign genetic element, 
one or more new spacers matching that element can be added to one end of the repeat-
spacer array, known as the leader [5].  The complete repeat-spacer array is transcribed 
and processed into crRNAs containing individual spacers, which are used to guide 
ribonucleoprotein complexes to corresponding protospacers when the matched element is 
seen again.  These complexes inactivate and/or degrade the targeted DNA, preventing 
infection or transfer [10].  In response to this threat, viruses can evade CRISPR targeting 
by acquiring random mutations in their protospacers [21,56]. 
CRISPR systems are divided into three types and numerous subtypes based on their cas 
gene content [38].  P. aeruginosa is known to harbor two subtypes of the Type I CRISPR 
system in its genome: I-E and I-F.  Type I-F CRISPRs are considerably more common 
than Type I-E, appearing in 33% of genomes versus 3% for Type I-E in a study of 122 
clinical isolates [14].  The Type I-F system has been shown to be fully functional as an 
immune system, conferring immunity to multiple temperate phages and adding new 
spacers in response to challenge with a lytic phage [13].  In addition to these genomically 
encoded CRISPRs, a Type I-C locus has recently been identified on an integrative and 
conjugative element present in some P. aeruginosa strains [8].  Spacers from all of these 
CRISPR subtypes have been shown to match known phage, with approximately a quarter 
of unique spacers uncovered in multiple studies matching phage or prophage [8,14], 
indicating that P. aeruginosa has recorded many encounters with phage in its CRISPR 
arrays. 
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Given the evidence for phage and prophage activity, phage influence on P. aeruginosa in 
the cystic fibrosis lung microbiome, and the potential for P. aeruginosa CRISPRs to 
record a history of phage interactions, we investigated the extent of interaction with 
phage by assessing CRISPR spacer content in a large pool of P. aeruginosa genomes 
from varied environments.  We found a diverse array of spacers matching a broad variety 
of sequenced phages and leveraged these spacers to investigate the population structure 
of these phages on a global scale.  Overall targeting of phages by host was investigated 
with respect to viral lifestyle, host environment, and host geographic location, revealing 
interactions between host and virus. 
Results 
A total of 1,184 P. aeruginosa genome sequences were compiled for analysis.  Nearly 
half of the strains in the dataset were isolated from cystic fibrosis patients (560), with the 
remaining strains originating from human samples not related to cystic fibrosis (421), 
human samples of undetermined cystic fibrosis status (43), environmental samples (34), 
strains derived from laboratory experiments (14), animal samples (1), or unknown origins 
(111).  These strains were collected in 26 countries and isolated over a range of 25 years 
(Figure 5.1).  The complete seven-locus multi-locus sequence type was determined for 
1,058 P. aeruginosa strains (Figure 5.2), showing that cystic fibrosis patients and other 
sources are intermingled on the tree, supporting established findings that cystic fibrosis 
patients are colonized by a variety of environmentally derived P. aeruginosa strains [34].  
Strains isolated from the same country, even from the same clinic, are also widely 
dispersed across the tree.  Exceptions to this include known epidemic strains of P. 
aeruginosa [31], which are clustered by geographic location (Figure 5.2).  To compare 
the phylogeny of CRISPR spacers to core genome phylogeny, a maximum parsimony 
tree of spacer presence was constructed for all CRISPR-containing strains (Figure 5.3).  
CRISPR spacers were organized into 729 unique repeat-spacer array loci, present in 754 
of the 1,184 strains.  We find that CRISPRs resolve differences among strains that are 
identical by MLST, but the CRISPR tree remains consistent with the MLST tree.  While 
some individual spacers are shared between strains of different sequence types, we do not 
observe the same entire array in strains of different sequence types.  This indicates that 
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although they evolve relatively rapidly, arrays do not move between lineages through 
recombination on this time scale. 
Protospacer typing of P. aeruginosa phage   
To determine whether spacers could be used to classify phage, we assembled a group of 
92 sequenced phage of P. aeruginosa, as well as 88 predicted prophage regions from 13 
fully sequenced P. aeruginosa genomes.  This set includes diverse prophage, with a total 
sequence length 10.7 Mbp and a pan-genome size of over 7.2 Mbp.  We divided our 
known and predicted phage library into phage clusters based on the fraction of the phage 
genomes aligned in pairwise BLAST searches (see methods).  We identified 31 phage 
clusters with at least two members, along with 15 clusters with a single representative 
(Figure 5.4A).   
Many of the larger clusters correspond well to established P. aeruginosa phage groups 
[29,54].  Cluster03 and Cluster08 contain the D3112-like and B3-like temperate 
transposable phages, respectively, while Cluster07 includes D3 and several related 
prophages.  The phiKMV-like podophages occupy Cluster06, and two species of lytic 
myophages form Cluster05 and Cluster10.  Interestingly, the filamentous phages are split, 
with Pf1 and several prophages forming Cluster04, while Pf3 did not cluster with any 
other phages in this dataset.  Cluster09 contains phage F10, as well as eight prophage, 
including related prophage found in LES strains; F10-like phage genes have also been 
identified in the variable genome of ST111 P. aeruginosa, a widespread nosocomial 
sequence type [58]. Many other known phages form smaller clusters, often including 
related prophages (see Table A.1 for a complete list of cluster members).  Eleven of the 
31 clusters, including the two containing the most members, contained only predicted 
prophage. 
In total we identified 3,152 unique spacer sequences from 1,184 P. aeruginosa strains.  A 
rarefaction curve of spacer sequences reveals that despite a broad sampling of available 
P. aeruginosa sequence data, not all spacers in the population have been observed 
(Figure 5.5A), showing this species holds a highly diverse collection of spacers.  To 
assess size of the phage genome space sampled by spacers targeting the same phage 
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region, we quantified how often the same protospacer region was sampled by CRISPR 
spacers (100% identity over at least 20 bp).  When combining spacers with this similarity, 
we retain 2,949 of the initial 3,152 spacer sequences.  A rarefaction curve built from 
these independent acquisitions shows that the same phage region is rarely targeted 
repeatedly by these hosts (Figure 5.5B).   
Many of the spacers identified match P. aeruginosa phage or prophage, with 1,592 
matching sequenced phage, 1,042 matching predicted prophage and 846 matching both.  
A total of 1364 spacers match neither phage nor prophage in this dataset, indicating that 
CRISPRs are sampling a set of foreign genetic elements much larger than the set of 
known P. aeruginosa phages.  All but 24 (18 independently sequenced, 6 predicted) of 
these 180 phage sequences contained a protospacer matched by at least one of the 
identified spacers.     
We next explored the feasibility of using protospacer matched to infer phage identities by 
analyzing the relationship between overall phage genome similarity and similarity of the 
protospacer content of the genomes. We determined a protospacer type, or the set of all 
spacer-matched sequences present in each phage genome, and then we clustered phage by 
similarity of protospacer sets.  For the most part, members of the same phage genome 
cluster were also found in the same protospacer cluster, with some exceptions.  In one 
case, while most phages from genome cluster 02 grouped together by protospacers in 
protospacer cluster 05, one phage was pulled into protospacer cluster 06 with phages 
from genome clusters 25 and 39, as it shared more protospacers with those phages than 
with those in its genome cluster (Figure 5.4B).  In two instances, a subset of members of 
a genome cluster with an especially high proportion of shared protospacers was pulled 
into an independent prototype cluster (genome cluster 01 into protospacers clusters 04 
and 15; genome cluster 06 into protospacer clusters 07 and 19; see Figure 5.4B).  While 
most genome clusters contain only one protospacer type, the majority of protospacer 
clusters (10/19) contained members of multiple genome clusters (Figure 5.4B), indicating 
that some protospacers are common to distantly related phages. Given this propensity for 
dispersed protospacers, we wanted to know how broadly these protospacers were 
conserved, and if there were also protospacers which could differentiate taxonomically 
106 
 
related groups of phages. For each genome cluster, the protospacers present were 
classified into one of five groups (Figure 5.4C): cluster-specific (found in all phages of 
that genome cluster and only that genome cluster), cross-cluster (found in all phages of 
the genome cluster, plus in at least one phage of another genome cluster), distributed 
(found in some phages of the genome cluster and also in some phages of other genome 
clusters), intermediate (found only in one genome cluster, but not in all phages), and 
individual (found only in a single phage in the entire dataset).  In 21 out of 27 
protospacer-containing phage genome clusters, 50% or more of protospacers were found 
to be present in multiple genome clusters (cross-cluster or distributed; Figure 5.4D), 
which led us to hypothesize that more conserved regions might be more highly targeted 
by spacers; however, we found that protospacers were not present in more strains in this 
dataset than non-matched regions of the phage genome (Figure 5.6).  While 64% of 
spacers with matches match only phages in a single cluster, a small number of spacers 
appear to broadly target up to 10 genome clusters, with five spacers targeting nine or 
more (Figure 5.7).  Interestingly, these five protospacers all match the same phage region, 
annotated as a conserved hypothetical protein. 
In addition to these inter-cluster protospacers, all but one protospacer-containing phage 
cluster has at least one spacer exclusive to that cluster, and over half the phage genome 
clusters had at least one cluster-defining protospacer (Figure 5.4D, Table A.2).  However, 
protospacers are not present more frequently in more conserved regions of the genome 
(Figure 5.6).  Indeed, for all but three clusters, more spacers match variable regions not 
present in all strains than core regions conserved cluster-wide (Figure 5.8). 
Spatial and temporal distribution of phage 
Finally, we used the distribution of CRISPR spacers within our P. aeruginosa isolate 
database to survey the phage distribution in time and space.  We began by constructing a 
maximum parsimony tree based on the presence and absence of CRISPR spacers and 
mapping on the location and environment in which they were found (Figure 5.3).  It is 
clear from this tree that unique spacer content does not differentiate strains from different 
countries; however, it is possible that spacer content could be more similar between 
strains from the same environment and geographic location, with strains living closer 
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together or in the same environment harboring more similar spacers.  To investigate this, 
we examined the proportion of spacers shared between each pair of strains within and 
between environments and found very similar levels of shared spacers within as well as 
between environments (Figure 5.9).  Shared spacers were also compared to the 
geographic distance between collection sites.  We found only a very weak negative 
correlation (Pearson’s r = -0.06, p < 2.2x10-16) between distance and shared spacers 
(Figure 5.10), showing that there is no appreciable relationship between environment or 
geography and spacer presence in P. aeruginosa. 
In addition to shared spacers between strains, the frequency of CRISPR presence was 
also analyzed with respect to the isolation environment and country (Figure 5.11).  
Strains isolated from cystic fibrosis patients were significantly more likely to have 
CRISPRs compared to strains from other environments (Chi-squared = 18.36, df  = 1, p-
value = 1.8x10
-5
) and lab-derived strains were more likely to lack CRISPRs (Chi-squared 
= 18.86, df  = 1, p-value = 1.4x10
-5
; chi-square for each environment vs. all other 
environments with Bonferroni correction).  No country of origin was significantly 
associated with increased or decreased CRISPR presence. 
To determine if some phage genome clusters were more frequently targeted by the 
CRISPR system, we quantified the number of protospacers per base pair of sequence in 
each phage genome.  Some phage groups are targeted significantly more or less 
frequently than most other groups (Figure 5.12); most notably clusters 03 and 18, which 
have significantly more protospacers per base pair than 26 and 25 out of 30 other clusters, 
respectively (one-way ANOVA with Games-Howell test).  In total, six clusters were 
more highly targeted than two-thirds of the groups identified, revealing that some phage 
types are indeed more heavily sampled by P. aeruginosa CRISPR systems, while others 
have very few protospacers.  In fact, four groups lack any protospacers matched by 
spacers in our library.  Notably, the most highly-targeted groups consist of predominantly 
temperate phages (Figure 5.4A).  Across the entire set of phages, temperate phages 
contain significantly more protospacers than phages characterized as lytic (Figure 5.13, 
Student’s t test, p < 2 x10-9). 
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To learn if this differential targeting of phage groups was related to their environment, we 
compared the number of hosts with a spacer matching each group to the number of hosts 
from each environment matching that group. Only five comparisons proved to be 
significantly different (p < 0.05), and in all cases, the group had fewer protospacers 
matched by spacers from that environment than the total population (Student’s t test with 
Bonferroni correction; Table 5.1).  We also considered that hosts in proximity to one 
another may see similar phage communities and thus have spacers targeting the same 
phages.  We clustered hosts by geographic distance and found that most phage genome 
clusters appear in multiple host geographic clusters, with a consistently high mean 
distance between geographic clusters each phage genome cluster is found in (Figure 
5.14).  Genome clusters matching relatively geographically close hosts have very few 
protospacers, indicating that they are rarely targeted by CRISPRs, and thus have less 
potential to be matched by hosts from different locations.  Among phage groups with 
moderate to high numbers of protospacers, no group appears restricted to a smaller 
geographic area, showing little association between geographic distance and acquisition 
of immunity to the same phage species and indicating that phage groups are widely 
distributed globally. 
While the majority of phage clusters are distributed across distance and environment, we 
hypothesized that hosts may encounter these phage clusters at different times relative to 
other clusters, as phages move among environments or geographic regions.  To quantify 
how relatively recently hosts had encountered particular spacers or spacers associated 
with each phage cluster, we assigned each spacer a newness value equal to its proximity 
to the leader end of its repeat-spacer array.  With respect to environment, no individual 
spacer was found to be more or less recent in any environment; however, spacers 
matching four phage clusters did show significantly different levels of newness (Figure 
5.15).  In three of the clusters, the same trends appear: matching spacers appear most 
recently in environmental strains, less recently in strains from cystic fibrosis patients, and 
least recently in non-cystic-fibrosis clinical isolates.  In the fourth cluster, spacers are 
found more recently in non-cystic-fibrosis strains than in those from cystic fibrosis 
environments (one-way ANOVA with Games-Howell test). 
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Geographically, there is a weak positive correlation between distance between hosts and 
absolute difference in array position of the same spacer (Pearson’s r=0.16, p < 2.2e-16), 
indicating little association between geographic distance and relative time of phage 
encounter on a spacer-by-spacer basis.  When spacers are partitioned by the phage groups 
they match, most correlations vary from weak negative to weak positive (Pearson’s r  
-0.33 to 0.24); however, in Cluster13 there is a significant moderate positive correlation 
between spacer position distance and geographic distance (r=0.55) (Table 5.2).  These 
limited correlations indicate that hosts in closer proximity generally do not necessarily 
encounter and acquire immunity to phages at similar times, although the moderate 
correlation present in Cluster13 indicates that it may be an exception to this rule   
Additionally, we analyzed the leadermost spacer in each array, which represents the 
phage the host most recently acquired immunity to, for hosts in each distance-based 
cluster. All geographic clusters contained hosts with leadermost spacers matching 
multiple phage clusters, with no geographic area clearly favoring a particular phage 
cluster (Figure 5.16). 
Discussion 
We have investigated the extent of interactions between P. aeruginosa and its phages 
through analysis of CRISPR spacer and protospacer content in a large pool of strains 
isolated from a diverse range of environments.  This analysis has demonstrated high 
spacer diversity in P. aeruginosa strains across environments, with identical CRISPR 
arrays rare between strains and little evidence of correlation between environment or 
location and CRISPR spacer similarity.  We also found that the global P. aeruginosa 
spacer pool contains spacers matching the majority of sequenced P. aeruginosa phages, 
as well as predicted prophages from complete P. aeruginosa genomes, making the spacer 
library a practical tool for investigating phage population structure.  Many spacers 
targeted sequence that appeared in multiple phage clusters, though nearly all phage 
clusters contained protospacers which were unique to that cluster and half had at least one 
cluster-specific spacer which appears in all strains, making it a marker for host encounter 
with that cluster.  Some phage clusters were found to be much more frequently targeted 
than others, particularly those containing predominantly temperate phage.  This targeting 
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was not associated with location and was only linked to environment in a small number 
of cases.  Additionally, we found that hosts from different locations generally do not 
encounter related phages at the same relative time, and phage clusters showed limited 
evidence of immune acquisition at different times in different environments. 
Evidence has long indicated that cystic fibrosis patients are colonized by P. aeruginosa 
strains from their environment which subsequently adapt to the lung niche [28].  Our 
work supports this view, with an MLST phylogeny placing strains from cystic fibrosis 
patients alongside those isolated from other human-associated and non-human-associated 
environments rather than in distinct environmentally defined clades.  Certain epidemic 
strains are exceptions to this rule.  LES-like strains are found exclusively in cystic 
fibrosis patients from the UK and Canada.  ST111 and ST235, a pair of multidrug 
resistant MLST types which are commonly found in hospital-acquired infections 
[22,59,62] were predominantly present in non-cystic-fibrosis clinical samples and absent 
from environmental samples, though ST235 appears in two cystic fibrosis patients from 
Copenhagen.  The other set of strains which appears to drive the formation of 
environment-specific clades is a longitudinal dataset of cystic fibrosis patients from 
Marvig et al. [40]; however, this is primarily due to clones at the MLST and spacer levels 
which are isolated from the same patient over time. A phylogeny built on spacer content 
also indicated that related strains inhabit multiple environments, with nearly half of well-
supported clades containing strains from multiple environments. Similarly, no clear 
geographic pattern emerges from either the MLST or spacer tree, where presence in 
multiple countries was more common than presence in a single nation for well-supported 
clades.  This lack of a geographic or environmental pattern in spacer presence shows that 
P. aeruginosa strains in varied environments around the world see similar phages, 
indicating that, like their hosts, they are broadly distributed globally and move freely 
between human-associated and non-human-associated environments. 
The widespread high spacer diversity observed in this dataset highlights the importance 
of the CRISPR system in P. aeruginosa-phage interactions.  Similar to a recent study 
focused on clinical isolates of P. aeruginosa [8], we found a diverse array of CRISPR 
spacer content which was consistent with the MLST phylogeny of the strains.  Unlike 
111 
 
Belkum et al., we focused our spacer extraction solely on chromosomally encoded 
CRISPR loci of Types I-F and I-E, excluding the Type I-C CRISPR loci infrequently 
encoded in mobile elements.  While we find potential Type I-C arrays in 23 of our 1,187 
genomes, we find our spacer library thoroughly samples P. aeruginosa phage space 
without these arrays.  The identified spacers cover protospacers present in the majority of 
sequenced P. aeruginosa phages as well as predicted prophages in the most complete 
genomes of P. aeruginosa available to date, indicating that the CRISPR system provides 
immunity to a broad spectrum of phages.  Shared protospacer sequences between phage 
clusters, even those with low overall genome similarity, are common and reflect the 
modular nature of some P. aeruginosa phages; for example, of the six well-studied 
prophages of the epidemic strain LESB58, two pairs of prophages share regions 7.5 kb 
and 13.5 kb in length [61].  Targeting these shared regions could be advantageous for a 
host strain, allowing acquisition of immunity to phages it has not encountered previously. 
In some instances, we observed significantly higher or lower than anticipated CRISPR 
presence.  In strains from cystic fibrosis patients, CRISPRs were present more frequently 
than in strains from other environments, pointing to a potentially important role in 
antiviral defense for P. aeruginosa strains inhabiting the cystic fibrosis lung.  
Interestingly, strains from the same environment do not share more spacers with one 
another than they do with strains from other environments, and spacer similarity did not 
strongly correlate with proximity of hosts to one another.  This further indicates that P. 
aeruginosa phages are broadly distributed spatially and among habitats, such that all 
types of hosts encounter all types of phage in a global panmictic population, or that the 
potential protospacer sequence space is large enough that hosts rarely sample the same 
part of the phage genome.  We found evidence supporting both of these hypotheses; 
protospacers which were exclusively found in single phage clusters were also distributed 
widely across different environments and locations, which supports the idea that phage 
are ubiquitously distributed, and there are few instances of closely related spacers 
appearing in different array contexts (Figure 5.5B), showing that hosts rarely gain 
immunity to a phage in the same way. 
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Among phage clusters, some were found to be targeted by hundreds of spacers, while 
four were targeted by none at all.  By far the most highly targeted phage group we found 
was Cluster03, which contained 259 unique protospacers; the individual phages in this 
cluster have approximately five protospacers per kb of genome.  This cluster contains 
D3112 and related temperate transposable phages, whose mosaic genomes have been 
heavily shaped by horizontal gene transfer among Mu-like and lambda-like phages [29]. 
Their overrepresentation in CRISPR loci may relate to their entry mechanism; these 
phage use Type IV pili as their receptors [12,51], and these pili are important for motility 
on solid surfaces and in viscous environments, and play a crucial role in biofilm structure 
[44].  In culture, virus-resistant P. aeruginosa mutants have been shown to typically 
delete the pilus to prevent viral attachment; however, in resistant strains where the pilus 
is not deleted, CRISPR spacers are added to confer immunity [13].  Selective pressure to 
maintain motility and proper biofilm structure in environments such as the cystic fibrosis 
lung may have pushed CRISPR immunity over pilus-compromising resistance 
mechanisms, leading to heavy targeting of these phages.  Consistent with this hypothesis, 
other phages which are known to use Type IV pili for entry, including B3-like phage 
(Cluster08), and F116 (Cluster25) also have moderate to high numbers of protospacers 
(Figure 5.12). 
Outside of Cluster03, temperate phages  were more heavily targeted than lytic phages, as 
previously observed in a smaller set of P. aeruginosa spacers, where all 132 spacers 
which perfectly matched phage matched temperate phage or prophage [14].  This skewed 
targeting could indicate that CRISPR immunity is used less frequently for defense against 
lytic phage, with other resistance mechanisms being used instead.  It is also possible that 
integrated phages are used competitively between P. aeruginosa strains, such as observed 
in experimental populations [11,33], and CRISPRs provide a way to specifically target 
phages used in this way by competitor strains.  However, these highly targeted clusters 
were highly targeted in all environments, indicating that these competitive dynamics are 
not restricted to any one host habitat. 
Despite the broad distribution of hosts across the globe and in different environments, we 
saw no strong correlation between geographic distance and how recently hosts had 
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acquired immunity to phage groups.  Hosts showed more recent acquisition in certain 
environments of spacers to four phage groups; in three cases, environmental strains had 
added spacers more recently than cystic fibrosis or clinical strains not linked to cystic 
fibrosis.  Two of these clusters, Cluster03 and Cluster08, are comprised of D3112-like 
and B3-like phages, while Cluster02 contains only prophage.  The fourth cluster shows a 
reversal of this pattern, with non-cystic-fibrosis strains adding spacers more recently than 
cystic fibrosis strains; however, only four spacers match this cluster overall, and this 
limited targeting may contribute to this result more than a meaningful difference in 
timing of spacer acquisition.  While the position of a spacer in its array can only tell us 
how recently a host gained immunity to a phage cluster relative to its encounters with 
other phages, this pattern indicates that P. aeruginosa strains in human-associated 
environments have encountered other types of phages since they last gained fresh 
immunity to these three phage types, while in the environment they are among the more 
recently encountered phages. 
Using variable CRISPR content for fine-scale tracking of infectious microbes has been 
proposed for clinical isolates of P. aeruginosa [8], as well as in other bacteria 
[1,17,24,27]; here, we propose to instead apply the wealth of information encoded in 
CRISPR arrays to prototyping, a method which can differentiate, track, and untangle the 
population structure of the phages rather than their hosts.  Prototyping allows us to 
leverage sequencing data to track which phage demographics in dynamic microbial 
populations such as P. aeruginosa, and could be applied to any microbial system where 
CRISPRs adequately sample the phage population.  Protospacers found exclusively in a 
single phage or phage cluster hold promise for identifying viral variants in the host 
genome; these cluster- or phage-specific spacers could be used to quickly classify a 
newly identified element.  Prototyping can be used to identify and track integrated phage 
or other mobile elements linked to critical determinants of pathogenic success, such as 
virulence and antibiotic resistance islands, or any variable segments of the host genome 
which distinguish stains from one another, such as the F10-like phage genes and mobile 
elements present in the widespread clinical P. aeruginosa isolate type ST111 [8,58] and 
the advantageous prophages of LES epidemic cystic fibrosis strains[61].  Prototyping also 
holds exciting implications for personalized medicine by enhancing the efficacy of phage 
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therapy.  Spacer libraries matching candidate phages for phage therapy could be used to 
identify hosts harboring immunity to the phage, thus predicting its effectiveness at 
eliminating infection.  Such a strategy could be used on a broad level, to identify classes 
of phage which are generally infrequently targeted by hosts, or on an individual level to 
provide a patient with maximally effective phage to which the infecting strain lacks 
immunity. 
These results depict a global population of P. aeruginosa and phage where many phage 
types are continuously circulating across a broad geographic area and in multiple 
environments.  Host repeat-spacer arrays bear evidence of encounters with many types of 
phage without a clear spatial or environmental pattern.  However, the significantly higher 
targeting of particular phage groups, largely consisting of temperate phages, reveals that 
hosts have different immune responses to different phage types.  Using a large library of 
spacers extracted from a large dataset spread across time, space and sample type allowed 
us to see how these phage were differentially targeted on a global scale rather than 
examining individual host-phage interactions.  Applying this type of surveillance to other 
host-virus systems could similarly reveal novel patterns in CRISPR targeting and viral 
population structure. 
Methods 
Host dataset selection 
The set of P. aeruginosa genomes and CRISPR arrays analyzed in this paper includes 
data from the following sources.  Reads associated with 458 P. aeruginosa strains 
cultured from patient samples collected from the Copenhagen Cystic Fibrosis Center at 
the University Hospital, Rigshospitalet, Denmark [40] were retrieved from the NCBI 
Sequence Read Archive (Accession ERP004853) and assembled as described below. 
Assembled genomes and sequencing reads of 24 P. aeruginosa strains described in 
Dettman et al. [20] were kindly provided by the authors.  Assembled genomes of 388 
strains described in [36] were obtained from GenBank (BioProject accession 
PRJNA264310).  All other complete and draft-stage P. aeruginosa genomes contained in 
the NCBI Nucleotide database were retrieved in September 2014 (310 genomes).  In 
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addition to complete genomes, CRISPR arrays from [14] were downloaded from NCBI 
(45 sequences). Three additional sets of CRISPR arrays were taken from metagenomic 
sequence of three cystic fibrosis patient sputum samples kindly provided by Katrine 
Whiteson and Yan Wei Lim of San Diego State University.  For all strains, basic 
metadata, including isolation location, sampling date, environment, and epidemic strain 
status were collected where possible. 
Quality filtering and genome assembly 
For all samples with sequencing reads available, reads were trimmed and quality filtered 
using Prinseq 0.20.4 [53]. Reads were trimmed from the left and right ends using a 5 nt 
sliding window with a minimum quality score of 30.  Reads were retained if they had a 
mean quality score of 30 and 1% or fewer ambiguous bases. The minimum read length 
was set to approximately two-thirds the anticipated read length, or 66 nt. Draft assemblies 
were generated with MIRA 4.0 [16] using the genome, denovo, and accurate parameters. 
Multi-locus sequence typing 
An established panel of seven markers [18] was used for MLST analysis of all strains.  
MLST loci were identified by BLASTn [2] of a representative known allele obtained 
from the Pseudomonas aeruginosa pubMLST website (http://pubmlst.org/paeruginosa/) 
[32] against genomes or contigs.  The best BLAST hit for each MLST locus was then 
BLASTed against a database of all known alleles for that locus, also obtained from the 
Pseudomonas aeruginosa MLST website.  Exact matches to one of these known alleles 
were assigned that allele’s ID number; hits with lower identity or incomplete coverage of 
the locus were investigated manually, and any identified as novel alleles were assigned 
new ID numbers >10,000.  Strains with inconclusive MLST alleles were removed from 
further MLST analysis.  A maximum-likelihood tree of concatenated MLST markers was 
constructed with RAxML [55] using the rapid bootstrapping algorithm plus maximum 
likelihood and GTRGAMMA nucleotide substitution model with 100 bootstrap 
replicates. 
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CRISPR identification and spacer extraction 
CRISPR loci were identified in genomes or contigs via BLASTn of known P. aeruginosa 
CRISPR repeats [14].  Parameters were adjusted for the short search sequence and to 
maximize hits covering the entire repeat length as follows: “-word _size 7 -gapopen 3  
-gapextend 2 -reward 1 -penalty -1”.  The minimum percent identity was set to 80 to 
allow for detection of degenerate repeat sequences.  Additionally, hits shorter than 24 bp 
in length were filtered from the results.  Sequences with a repeat of the same type both 
up- and downstream in the same orientation and that were less than 40 bp away from any 
neighboring spacers were considered spacers and extracted.  Each new unique spacer 
identified was numbered sequentially. A spacer rarefaction curve was computed in 
QIIME [15].   
In addition to spacer extraction, CRISPR repeat-spacer array ranges were declared as all 
consecutive repeats and spacers in the same orientation less than 500 bp away from one 
another.  Groups of repeats and spacers on different contigs, on the same contig/genome 
in different orientations, or on the same contig/genome but separated by more than 500 
bp were considered separate arrays.  
Clone correction 
To avoid biasing the dataset with multiple identical or nearly identical strains from 
longitudinal sampling in the Marvig et al. data, strains isolated from the same patient 
with identical MLST loci and CRISPR spacer content were condensed to a single 
representative strain.  This resulted in the removal of 365 strains from the dataset. 
Maximum parsimony spacer analysis 
A presence/absence matrix of all 3,152 spacers in all CRISPR-containing strains was 
constructed and used to generate a maximum parsimony tree using PAUP* 4.0b10 [57].  
One hundred bootstrap replicates were performed.  For analysis of metadata within 
clades, well-supported clades were defined as the largest clades with bootstrap support of 
50% or greater.  Well-supported clades consisting solely of identical strains from the 
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Marvig et al. dataset were removed from analysis as noted in the clone correction section 
above, as they would have been reduced to a single strain. 
Phage dataset selection and protospacer identification 
Genomes of all phage identified as infecting P. aeruginosa were downloaded from the 
NCBI Nucleotide database on June 23, 2015, totaling 92 unique phages.  Predicted 
prophages were identified in 13 complete P. aeruginosa genomes using VirSorter [52].  
Results were kindly provided by the authors prior to public availability of the program. 
Predictions from all three confidence categories were used, and 88 potential prophages 
were identified.  All phages were classified according to lifestyle (lytic, temperate, or 
non-lytic) based on their descriptions in the literature.  Together, these 180 phage and 
prophage were used for all phage-related analyses. 
Determination of phage pan-genome size 
The size of the P. aeruginosa phage pan-genome was determined using a custom python 
script.  This script hierarchically creates a non-redundant pseudo-genome based on a set 
of input DNA sequences. From this original collection of DNA sequences, the largest 
sequence is used as a scaffold for the non-redundant genome, and BLAST is performed 
to identify components of the remaining pool that are shared with the scaffold. Shared 
segments are removed from the pool, the largest contiguous sequence remaining in the 
pool is appended to the scaffold, and this cycle is repeated until the pool of sequences is 
empty. 
Protospacers in phage genomes were identified via BLASTn of all spacer sequences 
against the sequence of interest. The parameter “-task blastn-short” was used due to short 
query length. A minimum e-value of 0.01 was used to capture incomplete and imperfect 
matches, allowing up to four mismatches over a full-length match. Partial-length matches 
were extended to cover the full spacer length using clDB [7].  
Assignment of phages to genome clusters 
To assign phages to clusters, all phage genomes were compared to one another using 
BLASTn (e=0.001).  For each pair of genomes, the proportional length alignment (PLA), 
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or total length aligned by BLAST over the length of the query, was calculated and used 
as our measure of similarity between phages. MCL [23] was used to cluster phage groups 
into networks with edges weighted by PLA, with a minimum PLA cutoff of 0.2. 
Clustering hosts by distance 
For each host where the sampling location was known, coordinates were determined 
using the GeoNames geographical database [26].  If the city or other specific location 
was not provided, the capital or seat of the smallest known political region was used 
instead.  Hosts were divided into 33 geographical clusters using the modularity 
calculation in Gephi [6], which implements the Louvain Method for finding 
subcommunities within larger networks [9].  Edges were weighted by the inverse distance 
between each host pair. 
Statistical analysis 
All statistical tests were performed in R versions 3.2.2-3.2.4 [47].  Games-Howell tests 
were performed using the userfriendlyscience package [45].  Plots were generated in R 
using the ggplot2 package [60]. 
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Figures and Tables 
 
Figure 5.1.  Isolation environment, geographical location, and year of isolation for 1,184 P. 
aeruginosa sequences used in this study.  “Human” refers to strains known to have been 
isolated from a human where the cystic fibrosis status of the person is unknown.  “CF clones” 
denotes strains identical at the MLST and CRISPR level, which were removed from further 
analysis. 
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Figure 5.2.  Concatenated maximum likelihood MLST tree of P. aeruginosa strains. 
Bootstrap values >70 are indicated by circles. Inner ring: environment; middle ring: country of 
isolation, outer ring: CRISPR-type.  Strains with no CRISPR spacers are shown in white; strains 
with a unique CRISPR-type are shown in black. 
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Figure 5.3.  Maximum parsimony tree of spacer content in CRISPR-containing strains. 
Inner ring: environment; middle ring: country of isolation, outer ring: CRISPR-type. Strains with 
a unique CRISPR-type are shown in black.  
  
122 
 
 
Figure 5.4.  Phage clusters and defining protospacers.  
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Figure 5.4. (cont.) 
A. Identified phage genome clusters. Numerical identifiers are to the lower right of each cluster.  
Each node represents a phage sequence. Line width represents sequence shared between phages; 
color indicates phage lifestyle (red, lytic; blue, temperate; purple, prophage; orange, non-lytic; 
green, uncertain).  B. Protospacer type clusters.  Members of the same genome cluster share a 
node color and are connected by lines, as in A, showing genome clusters that are pulled together  
into the same protospacer cluster, or pulled apart into separate protospacer clusters. The colors 
representing each genome cluster number are shown in the legend at the bottom.  C. 
Classifications of protospacer types based on presence within and between phage genome 
clusters. Gray bars represent individual phages; orange segments represent protospacers.  
Protospacers in the cluster-defining, intermediate, and individual classes are useful for 
discriminating between genome clusters. D. Classification of protospacers matching each phage 
cluster.  Dots show number of protospacers in each phage cluster at each level of conservation.  
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Figure 5.5.  Spacer rarefaction curves.  A. Rarefaction curve of spacers identified in 1,184 
Pseudomonas aeruginosa genomes. B. Rarefaction curve of spacers observed in unique contexts 
(different trailer-side spacer). 
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Figure 5.6.  Protospacers are not more conserved than general phage sequence.  The black 
boxplot represents the number of phage genomes containing each protospacer, with the mean 
number of genomes containing non-protospacer phage sequence +/- sd is shown in red.  The 
center line of the boxplot represents the median; the upper and lower lines mark the first and third 
quartiles, respectively.  Whiskers extend to 1.5x the interquartile range, points outside this range 
are shown as black dots. 
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Figure 5.7.  Distribution of the number of phage genome clusters hit by spacers.  Only phage 
genome clusters with two or more members are considered. 
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Figure 5.8.  Spacers targeting core or variable sequence in each phage cluster.  For each 
cluster, core (red) is defined as protospacer sequence present in all phages in that cluster; variable 
(blue) sequence is missing from at least one cluster member. 
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Figure 5.9.  Proportion of spacers shared between P. aeruginosa host pairs vs. the 
environment from which they were isolated. Error bars show +/- sd. 
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Figure 5.10.  Proportion of spacers shared between P. aeruginosa host pairs vs. the 
geographic distance between isolation locations.  Only a very weak correlation (Pearson’s r= 
-0.06) is observed. 
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Figure 5.11.  CRISPR-containing versus CRISPRless strains in each environment or 
country of isolation.  CRISPR-containing strains were significantly more common in strains 
from cystic fibrosis (p=1.82x10
-5
), while CRISPRless strains were significantly more common in 
lab-derived strains (p=1.41x10
-5
).  (Chi-square for each environment or country vs. all others 
with Bonferroni correction). 
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Figure 5.12.  CRISPR targeting of phage clusters. Upper: Protospacers per base pair of 
sequence for each phage cluster.  The center line of the box represents the median; the upper and 
lower lines mark the first and third quartiles, respectively.  Whiskers extend to 1.5x the 
interquartile range, points outside this range are shown as black dots. Lower:  Count of other 
clusters from which each phage cluster has a significantly higher (red) or lower (blue) number of 
protospacers per base pair (one-way ANOVA with Games-Howell test, p < 0.05). 
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Figure 5.13.  Spacers target temperate phages. Left: Number of protospacers per base pair of 
sequence in 180 sequenced and predicted phage categorized by lifestyle. Right:  Protospacers per 
base pair is significantly higher in temperate phages than lytic phages (Student’s t-test, 
p=1.56x10
-9
). The center line of the box represents the median; the upper and lower lines mark 
the first and third quartiles, respectively.  Whiskers extend to 1.5x the interquartile range, points 
outside this range are shown as black dots. 
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Figure 5.14.  Mean distance between host geographic clusters matched by phage genome 
clusters is generally high.  Genome clusters are shown on the x-axis, with the mean distance 
between geographic clusters which contain hosts matching each phage genome cluster on the y-
axis.  Dot size is scaled to the number of geographic clusters with hosts matching each phage 
cluster. 
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Figure 5.15.  Spacer distance from leader varies across environments for four phage groups. 
For Clusters 02, 03, and 13, all environments are significantly different from one another; in 
Cluster08, horizontal bars designate which environments are significantly different. *, p <0.01. 
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Figure 5.16.  Host geographic clusters target multiple phage clusters with their recently-
acquired spacers.  Each color corresponds to a phage cluster; the height of each colored band 
corresponds to the number of hosts with CRISPR spacers that match that phage cluster. 
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Table 5.1.  Phage clusters matched by significantly fewer spacers from an environment than 
the total phage population. 
Cluster Environment p  Mean spacers per host 
(Cluster) 
Mean spacers per host 
(All) 
cluster04 nonCF 2.59E-05 1.35 2.51 
cluster06 Environmental 1.59E-69 0 0.18 
cluster13 Environmental 1.59E-69 0 0.18 
cluster20 Environmental 1.59E-69 0 0.18 
cluster27 Environmental 1.59E-69 0 0.18 
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Table 5.2.  Correlation between host geographic distance and position in repeat-spacer 
array between spacers matching phage clusters. 
 
 
  
Cluster r p 
cluster01 -0.07 3.82E-21 
cluster02 0.02 7.49E-38 
cluster03 0.05 0 
cluster04 0.25 5.28E-71 
cluster05 0.05 1.18E-06 
cluster06 0.05 6.92E-01 
cluster07 0.02 2.94E-66 
cluster08 0.09 0 
cluster09 0.01 2.95E-34 
cluster10 0.10 1.21E-07 
cluster12 0.02 1.02E-09 
cluster13 0.55 4.37E-04 
cluster14 0.03 7.18E-04 
cluster15 0.11 3.93E-08 
cluster16 0.01 7.85E-01 
cluster17 0.10 3.71E-08 
cluster18 0.01 3.85E-33 
cluster19 0.02 1.47E-06 
cluster20 0.15 3.93E-01 
cluster22 NA NA 
cluster23 0.02 2.02E-17 
cluster24 0.10 3.04E-05 
cluster25 0.03 3.21E-24 
cluster26 0.01 1.11E-27 
cluster27 -0.33 5.19E-01 
cluster29 0.03 2.27E-08 
cluster30 -0.11 2.48E-01 
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CHAPTER 6 
Concluding Remarks and Future Directions 
CRISPR Diversity in Simulated Populations and Translation to Natural Populations 
Through the use of an eco-evolutionary model of host-virus coevolution mediated by 
CRISPR immunity, we were able to peer into the evolution of CRISPR diversity and how 
it can lead to complex host populations with distributed CRISPR immunity to the resident 
viruses. In these simulated populations, phenotypically identical strains with underlying 
genotypic diversity contribute to a stable host population which is better able to limit or 
eliminate growth of predatory viruses.  These findings provide evolutionary context for 
observations of high CRISPR diversity in species such as Sulfolobus islandicus [2] and 
crucially provides novel metrics for assessing distributed immunity in experimental and 
natural populations.   
While the findings and metrics derived from these simulations are valuable, they require 
further testing on real-world microbe-virus communities to determine if the observed 
CRISPR diversity also manifests in living systems, and if host stability and viral 
instability follow distributed immunity as the model predicts.  To this end, we chose two 
discrete human-associated microbial communities: the vaginal microbiomes of pregnant 
women and the lung microbiomes of cystic fibrosis patients.  In both, we found 
surprisingly limited diversity among CRISPR-containing strains within an individual 
human host, which stands in stark contrast to the simulated populations and previous 
observations in S. islandicus populations.  This low diversity may result from many 
aspects of the host-viral ecology in these environments.  They may encounter fewer 
viruses overall, or fewer lytic viruses, which would decrease evolutionary pressure to 
maintain diversified CRISPR immunity.  The viruses present in these systems may also 
be predominantly temperate, with the potential to carry valuable genes for virulence, 
antibiotic resistance, or many other advantageous processes.  Many non-CRISPR 
mechanisms of viral resistance exist in microbes [5], and these particular environments 
may favor those mechanisms over CRISPR immunity.   
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CRISPRs in the Vaginal Microbiome 
To better understand the low CRISPR diversity in these environments, further work is 
required to characterize the host and viral populations, their CRISPR-mediated 
interactions, and other viral resistance mechanisms.  In the vaginal microbiome, 
sequencing and analysis of paired bacterial and viral metagenome samples would be 
valuable for following the trajectory of the viral population in parallel to tracking 
CRISPR changes in the hosts.  Conducting sampling outside of pregnancy may also help 
clarify the presence of CRISPR diversity.  The vaginal microbiome changes markedly 
during pregnancy [1,7,8], and accordingly we observed major shifts in both species and 
CRISPR-type abundance over the course of pregnancy and the postpartum period  in the 
subjects in our study.  These shifts may have led to loss of diversity due to bottlenecking 
of CRISPR-containing species which were reduced in abundance; samples taken during a 
time period when the community is less subject to disturbance may better assess CRISPR 
diversity in the vaginal microbiome under less disruptive circumstances. 
CRISPRs in the Cystic Fibrosis Lung Microbiome 
While our initial foray into CRISPR diversity in the cystic fibrosis lung microbiome 
uncovered no within-sample diversity in Pseudomonas aeruginosa CRISPRs, evidence of 
lytic action by temperate phages in LES-infected cystic fibrosis patients [4] as well as 
continued research into phage therapy as a treatment for P. aeruginosa [3] underscore the 
importance of understanding host-virus interactions in this environment.  CRISPRs in 
particular may be an important mechanism of resistance to phages which use Type IV pili 
as part of their entry mechanisms. These pili are involved in biofilm formation, which is 
an important part of P. aeruginosa persistence in the lung [6], so deleting or modifying 
them to avoid infection may not be an optimal strategy in this environment.  Given these 
factors, it is quite possible that P. aeruginosa CRISPR diversity exists within some cystic 
fibrosis patients.  Our sample only contained four patients with detectable P. aeruginosa 
CRISPRs; a larger sample size may find lung environments with strains that have 
diversified their CRISPRs. Additionally, many other bacterial species which contain 
CRISPRs inhabit the lung; in just two patients, we identified 19 non-Pseudomonas 
CRISPR repeats from 14 different bacterial genera, including Rothia and Streptococcus.  
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These bacteria may each have their own types of interactions with phages, levels of 
reliance on CRISPR immunity versus other resistance mechanisms, and levels of 
CRISPR diversity in the population. Efforts to characterize the loci associated with these 
repeats and any diversity they might harbor are ongoing, and very preliminary results 
indicate that some samples do have species with multiple coexisting CRISPR alleles 
(Samantha DeWerff, personal communication). We are optimistic that among these we 
will find species in which we can observe the effects of distributed immunity in a natural 
microbial population. 
Protospacer Typing: Leveraging Spacer Diversity to Track Phage Ecology 
After observing the variation in P. aeruginosa CRISPR spacers between cystic fibrosis 
patients, we were inspired to assess diversity levels in the global population of P. 
aeruginosa.   We found an incredible array of spacers, with highly diverse spacer content 
in strains from both cystic fibrosis patients and other environments around the world.  
This diversity reflects the wide variety of phage infecting P. aeruginosa, and we 
discovered that these spacers can be used to “protospacer type” phages, allowing us to 
identify and track which phage types these strains have encountered, providing ecological 
insight into phage distribution and migration.  Thus far, we have only used protospacer 
typing on P. aeruginosa; however, this method should prove viable in any microbial 
system where the host has CRISPRs which actively sample phages or other elements of 
interest.  In P. aeruginosa, protospacer typing confirmed panmictic host and phage 
populations; in systems which display stronger host biogeographic patterns or 
environmental differentiation, protospacer typing could be used to investigate if phages 
or mobile elements follow these patterns as well.  
In addition to investigating phage ecology, there are numerous exciting applications for 
protospacer typing; for example, bacterial strains present in an infection could be 
screened for CRISPR spacers using spacer libraries matching possible phage therapy 
cocktails, allowing practitioners to choose the most effective treatment on a personalized 
level.  This method could also be used to quickly identify and group prophages or other 
integrated mobile elements sampled by CRISPRs.  Such elements are often of great 
interest because they can carry advantageous genes such as virulence factors, antibiotic 
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resistance genes, and genes encoding new metabolic functions, and protospacer typing 
provides the ability to rapidly identify and classify both well-studied and novel elements. 
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APPENDIX A 
Tables 
Table A.1. Complete List of P. aeruginosa Phage Clusters. 
Phage Name Phage Cluster Protospacer Cluster 
PAO1_627_663 01 4 
PA14_643_675 01 4 
PA7_4868_4912 01 15 
PA7_671_781 01 15 
LESB58_617_638 01 4 
39016_575_650 01 4 
M18_617_636 01 4 
NCGM2.S1_5520_5596 01 4 
DK2_620_639 01 4 
B136-33_623_643 01 4 
RP73_618_637 01 Unclustered 
PA1_4213_4248 01 4 
MTB-1_627_664 01 4 
LES431_619_640 01 4 
SCV20265_625_644 01 4 
PA14_2245_2363 02 6 
PA7_2282_2462 02 10 
LESB58_2329_2530 02 6 
39016_2947_3027 02 9 
39016_3135_3235 02 6 
39016_3305_3399 02 6 
NCGM2.S1_3802_3895 02 6 
DK2_2068_2214 02 6 
B136-33_2187_2284 02 6 
RP73_2844_3040 02 6 
MTB-1_2189_2286 02 6 
LES431_2276_2477 02 6 
SCV20265_2319_2506 02 6 
DMS3 03 2 
MP22 03 2 
MP29 03 2 
MP38 03 2 
LESB58_1604_1659 03 2 
39016_5273_5326 03 2 
PA1/KOR/2010 03 2 
MP42 03 2 
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Table A.1. (cont.) 
Phage Name Phage Cluster Protospacer Cluster 
D3112 03 2 
NCGM2.S1_5372_542
4 
03 2 
PaMx73 03 2 
LES431_1548_1603 03 2 
JD024 03 2 
PAO1_734_745 04 5 
PA14_3998_4010 04 5 
PA7_5142_5215 04 5 
LESB58_4251_4263 04 5 
M18_4418_4431 04 5 
M18_4883_4901 04 5 
B136-33_4385_4398 04 5 
MTB-1_5097_5111 04 5 
LES431_4198_4210 04 5 
SCV20265_5267_5284 04 5 
Pf1 04 5 
PB1 05 3 
LBL3 05 3 
LMA2 05 3 
14-1 05 3 
SN 05 3 
JG024 05 3 
NH-4 05 3 
PaMx13 05 3 
KPP12_DNA 05 3 
SPM-1 05 3 
F8 05 3 
PT5 06 7 
LKD16 06 19 
LUZ19 06 7 
PT2 06 7 
phikF77 06 19 
phiKMV 06 7 
vB_Pae-TbilisiM32 06 7 
MPK7 06 7 
MPK6 06 7 
MBL 06 7 
LESB58_2583_2651 07 1 
39016_2143_2228 07 1 
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Table A.1. (cont.) 
Phage Name Phage Cluster Protospacer Cluster 
vB_PaeS_PMG1 07 1 
PA1_1737_1784 07 1 
LES431_2530_2598 07 1 
SCV20265_1323_1386 07 1 
D3 07 1 
39016_5137_5191 08 2 
NCGM2.S1_4860_4914 08 2 
JBD18 08 2 
JBD25 08 2 
JBD67 08 2 
B3 08 2 
SCV20265_2698_2750 08 2 
LESB58_1360_1425 09 1 
LESB58_800_862 09 1 
M18_1344_1415 09 1 
PA1_1496_1566 09 1 
MTB-1_4320_4398 09 1 
LES431_1304_1369 09 1 
F10 09 1 
JG004 10 8 
PaP1 10 8 
PaMx12 10 8 
vB_PaeM_C2-10_Ab1 10 8 
PAK_P2 10 8 
PAK_P4 10 8 
PAK_P1 10 8 
LUZ24 11 Unclustered 
MR299-2 11 Unclustered 
PaP3 11 99 
vB_PaeP_C1-14_Or 11 Unclustered 
vB_PaeP_p2-10_Or1 11 Unclustered 
phiIBB-PAA2 11 Unclustered 
TL 11 Unclustered 
PA7_4273_4372 12 9 
DK2_4747_4840 12 9 
B136-33_4708_4807 12 9 
RP73_983_1081 12 9 
PA1_4626_4723 12 9 
MTB-1_4864_4955 12 9 
vB_Pae-Kakheti25 13 Unclustered 
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Table A.1. (cont.) 
Phage Name Phage Cluster Protospacer 
Cluster 
PaMx10 13 Unclustered 
PaMx42 13 6 
vB_PaeS_SCH_Ab26 13 1 
73 13 21 
CHA_P1 14 3 
PAK_P5 14 3 
P3_CHA 14 3 
PAK_P3 14 3 
KPP10 14 3 
LIT1 15 12 
PA26 15 12 
vB_PaeP_C2-10_Ab09 15 12 
PA7_141_160 16 Unclustered 
PA7_45_116 16 4 
39016_4_77 16 17 
PA7_2684_2749 17 14 
39016_2751_2807 17 14 
PA1_3627_3647 17 Unclustered 
phi297 18 1 
NCGM2.S1_2862_2938 18 1 
YMC/01/01/P52_PAE_BP 18 1 
phiCTX 19 11 
MTB-1_5610_5659 19 11 
SCV20265_5782_5829 19 11 
YuA 20 13 
MP1412 20 13 
M6 20 13 
PaMx32 21 Unclustered 
PaP2 21 Unclustered 
119X 21 Unclustered 
LESB58_4626_4666 22 23 
LES431_4573_4600 22 Unclustered 
DK2_2836_2922 23 11 
SCV20265_3070_3116 23 5 
39016_819_882 24 18 
NCGM2.S1_1519_1583 24 18 
H66 25 10 
F116 25 10 
PAJU2 26 1 
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Table A.1. (cont.) 
Phage Name Phage Cluster Protospacer Cluster 
MTB-1_3073_3155 26 1 
39016_6005_6024 27 20 
NCGM2.S1_5852_5868 27 20 
PA14_1790_1819 28 Unclustered 
39016_3829_3856 28 Unclustered 
M18_2482_2554 29 10 
RP73_2687_2759 29 10 
PaMx28 30 16 
PaMx74 30 16 
phiKZ 31 Unclustered 
PA7 31 Unclustered 
phiEL 32 1 
PA7_350_367 33 5 
PP7 34 Unclustered 
PA1_5723_5781 35 11 
Pf3 36 Unclustered 
B136-33_1185_1197 37 22 
PaMx25 38 12 
PaMx11 39 1 
PaMx31 40 3 
PaBG 41 2 
PhiPA3 42 Unclustered 
PA7_4959_4986 43 17 
PA11 44 3 
LUZ7 45 4 
LKA1 46 Unclustered 
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Table A.2. Protospacers unique to a single phage genome cluster (cluster-defining, 
intermediate, or individual).  Clusters without protospacers not shown. 
Cluster Cluster-Defining Intermediate Individual 
cluster01  24, 263, 319, 496, 576, 
658, 683, 695, 746, 843, 
855, 956, 972, 1070, 
1130, 1131, 1158, 1228, 
1311, 1312, 1417, 1428, 
1631, 1703, 2083, 2305, 
2359, 2360, 2392, 2402, 
2545, 2551, 2657, 2740, 
2761, 2775, 2826, 2852, 
3024 
1245, 1251, 1554, 1831, 
2258, 2440, 2790, 3071, 
3080 
cluster02  69, 237, 254, 408, 486, 
516, 1757, 1941, 2765, 
2824, 2835, 3014 
52, 65, 72, 129, 149, 
175, 218, 241, 336, 365, 
440, 450, 480, 531, 538, 
557, 599, 654, 655, 754, 
807, 844, 948, 949, 974, 
978, 982, 1003, 1095, 
1161, 1168, 1203, 1238, 
1244, 1340, 1432, 1697, 
1806, 1812, 1824, 1895, 
1929, 2070, 2228, 2231, 
2236, 2244, 2273, 2299, 
2374, 2385, 2485, 2533, 
2568, 2583, 2825, 2844, 
2860, 2885, 2886, 2889, 
2941, 2944 
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Table A.2. (cont.) 
Cluster Cluster-Defining Intermediate Individual 
cluster03 180, 182, 209, 216, 228, 
358, 453, 1189, 1590, 
1596, 1789, 2195, 2240, 
2498, 2541, 2586, 2694, 
2704, 2780, 2792 
44, 56, 102, 181, 184, 
185, 210, 233, 242, 243, 
245, 259, 270, 271, 302, 
303, 344, 345, 407, 426, 
488, 489, 503, 504, 584, 
585, 586, 587, 603, 608, 
633, 706, 769, 781, 814, 
834, 842, 858, 950, 984, 
1047, 1050, 1057, 1108, 
1111, 1119, 1184, 1194, 
1280, 1295, 1400, 1420, 
1453, 1457, 1465, 1471, 
1478, 1491, 1564, 1572, 
1595, 1670, 1692, 1693, 
1786, 1813, 1879, 1897, 
1898, 1917, 1919, 1920, 
1924, 1931, 1934, 1935, 
1936, 2000, 2112, 2174, 
2267, 2272, 2290, 2435, 
2486, 2668, 2751, 2753, 
2781, 2791, 2803, 2880, 
2884, 2914, 2915, 2918, 
2932, 2948, 2951, 3018, 
3078, 3079, 3083, 3105, 
3140 
1659, 1930, 1990, 2949 
cluster04 130, 435, 465, 876, 
1858, 1903, 1906, 1908, 
2057 
127, 406, 1850, 1859, 
1905, 1909, 2723, 2724, 
2728, 2729, 2731, 2732, 
2734, 2735, 2736, 2744, 
2745, 2748, 2749, 3049, 
3050, 3051, 3055, 3056, 
3062, 3063 
31, 146, 634, 1167, 
1907, 2746 
cluster05 2957 84, 1192, 2821  
cluster06  423, 1365, 2366  
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Table A.2. (cont.) 
Cluster Cluster-Defining Intermediate Individual 
cluster07  59, 143, 208, 308, 540, 
549, 622, 628, 671, 798, 
818, 831, 847, 958, 959, 
1069, 1230, 1248, 1315, 
1385, 1505, 1508, 1588, 
1632, 1665, 1748, 1775, 
1815, 1978, 2079, 2089, 
2136, 2153, 2154, 2183, 
2199, 2229, 2304, 2319, 
2320, 2472, 2684, 2805, 
2849, 2862, 2865, 2866, 
2867, 2868, 2910, 2936 
21, 160, 193, 306, 415, 
659, 677, 690, 762, 780, 
782, 792, 945, 1114, 
1115, 1225, 1319, 1352, 
1456, 1507, 1597, 1634, 
1819, 1828, 1951, 2381, 
2382, 2426, 2430, 2462, 
2595, 2764, 2773, 2830, 
2840, 2938, 2964, 2984, 
3130 
cluster08 1738, 2082 98, 162, 172, 173, 249, 
348, 359, 367, 368, 380, 
392, 422, 446, 482, 533, 
597, 609, 681, 704, 767, 
799, 809, 832, 888, 922, 
934, 968, 1055, 1138, 
1163, 1199, 1212, 1279, 
1287, 1474, 1562, 1714, 
1715, 1739, 1773, 1838, 
1845, 1851, 1852, 1853, 
1961, 1976, 1977, 1995, 
1996, 1997, 1998, 2023, 
2269, 2300, 2332, 2396, 
2453, 2481, 2518, 2585, 
2613, 2614, 2623, 2629, 
2795, 2804, 2854, 2906, 
3046, 3111, 3116, 3118, 
3132 
315, 366, 541, 630, 990 
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Table A.2. (cont.) 
Cluster Cluster-Defining Intermediate Individual 
cluster09 64, 556, 562, 666, 714, 
761, 778, 981, 983, 
1010, 1246, 1448, 1684, 
2051, 2519, 2738 
46, 78, 91, 103, 139, 
157, 187, 320, 356, 357, 
434, 454, 471, 591, 619, 
645, 652, 679, 751, 764, 
841, 879, 928, 941, 944, 
971, 997, 1032, 1033, 
1037, 1133, 1190, 1211, 
1218, 1416, 1472, 1570, 
1737, 1756, 1835, 1894, 
2095, 2115, 2175, 2219, 
2220, 2330, 2352, 2474, 
2483, 2508, 2512, 2538, 
2539, 2540, 2553, 2571, 
2647, 2848, 2878, 3028, 
3138 
55, 457, 487, 546, 570, 
571, 775, 862, 1100, 
1128, 1350, 1512, 1620, 
1746, 1847, 2041, 2061, 
2092, 2137, 2139, 2208, 
2227, 2256, 2383, 2399, 
2493, 2552, 2669, 2670, 
2774, 2853, 2859, 2966 
cluster10  427  
cluster12 8, 192, 400, 811, 835, 
859, 1117, 1118, 1288, 
1628, 1702, 1882, 2158, 
2355, 2361, 2511, 2768, 
2769, 2892, 2943 
19, 647, 860, 1012, 
1013, 1281, 1630, 1639, 
1705, 1950, 2243, 2266, 
2556, 2632, 3077 
2685, 2959 
cluster13   2386, 2935 
cluster14 502 863  
cluster15   3 
cluster16   1068 
cluster17   827, 873, 2363, 2873, 
2940 
cluster18 287, 322, 347, 402, 416, 
513, 728, 897, 899, 
1175, 1645, 1777, 1964, 
1981, 2030, 2049, 2050, 
2052, 2424, 2438, 2497, 
2560, 2603, 2604, 2608, 
2996 
251, 355, 360, 468, 921, 
1198, 1296, 1347, 1656, 
1699, 1704, 2012, 2087, 
2415, 2484, 2606, 2618, 
2783, 3149 
7, 235, 252, 383, 515, 
870, 901, 986, 1110, 
1351, 1397, 1475, 1494, 
1728, 1889, 1940, 1980, 
2053, 2121, 2255, 2406, 
2605, 2607, 2963, 2992, 
3020 
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Table A.2. (cont.) 
Cluster Cluster-Defining Intermediate Individual 
cluster19 152, 154, 199, 264, 346, 
393, 394, 451, 572, 574, 
579, 580, 614, 692, 732, 
889, 914, 926, 927, 992, 
993, 999, 1039, 1080, 
1107, 1164, 1176, 1221, 
1727, 1809, 1866, 1878, 
1933, 2062, 2162, 2176, 
2197, 2234, 2329, 2347, 
2590, 2616, 2619, 2630, 
2634, 2778, 2847, 2969 
106, 107, 220, 333, 560, 
910, 915, 975, 1092, 
1575, 1910, 1911, 1948, 
2177, 2505 
425, 568, 848, 1278, 
1576, 2097, 2620, 2621, 
2971 
cluster20   1234 
cluster22   2558 
cluster23   4, 39, 136, 137, 151, 
176, 191, 194, 195, 200, 
206, 291, 317, 327, 405, 
410, 412, 462, 490, 500, 
532, 578, 702, 707, 725, 
755, 839, 849, 874, 890, 
898, 907, 979, 1000, 
1104, 1105, 1122, 1135, 
1148, 1155, 1157, 1214, 
1215, 1233, 1242, 1266, 
1335, 1348, 1359, 1373, 
1408, 1409, 1433, 1438, 
1477, 1479, 1520, 1521, 
1541, 1549, 1565, 1587, 
1608, 1609, 1616, 1687, 
1698, 1707, 1747, 1849, 
1857, 2044, 2069, 2072, 
2182, 2185, 2194, 2209, 
2274, 2292, 2293, 2316, 
2495, 2600, 2635, 2643, 
2687, 2688, 2716, 2720, 
2742, 2800, 2841, 2842, 
2843, 2922, 2928, 2968, 
2979, 2989, 3006, 3008, 
3009, 3010, 3011, 3032, 
3033, 3059, 3072, 3102, 
3141, 3151 
cluster24 253, 595, 668, 1872   
 
  
158 
 
Table A.2. (cont.) 
Cluster Cluster-Defining Intermediate Individual 
cluster25 279, 280, 511, 512, 1106,  
1556, 1721, 1793, 2337,  
2353, 2857 
123, 285, 293, 476, 711, 
712, 713, 745, 846, 
1082, 1083, 1084, 2004, 
2534, 2535, 2939 
cluster26 1, 70, 81, 85, 469, 891,  
906, 1014, 1284, 1379,  
1452, 1594, 1700, 1861,  
1862, 2016, 2171, 2172,  
2201, 2490, 2548, 2712,  
2798, 2829 
17, 40, 41, 42, 87, 120, 
150, 203, 204, 229, 328, 
332, 337, 375, 387, 430, 
452, 473, 491, 565, 593, 
626, 669, 675, 708, 736, 
757, 758, 759, 765, 770, 
923, 947, 988, 1021, 
1034, 1062, 1088, 1123, 
1134, 1196, 1209, 1217, 
1222, 1243, 1285, 1290, 
1354, 1380, 1410, 1422, 
1439, 1467, 1527, 1530, 
1561, 1591, 1637, 1647, 
1655, 1711, 1712, 1719, 
1730, 1732, 1767, 1779, 
1788, 1801, 1805, 1860, 
1921, 1963, 2025, 2038, 
2055, 2066, 2099, 2102, 
2108, 2122, 2123, 2132, 
2133, 2135, 2155, 2160, 
2181, 2200, 2205, 2211, 
2214, 2216, 2241, 2246, 
2254, 2259, 2276, 2314, 
2351, 2370, 2384, 2431, 
2434, 2461, 2480, 2504, 
2509, 2513, 2514, 2529, 
2530, 2594, 2664, 2713, 
2785, 2796, 2801, 2827, 
2869, 2877, 2985, 3082 
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Table A.2. (cont.) 
Cluster Cluster-Defining Intermediate Individual 
cluster29 105, 144, 156, 188, 442,  
771, 911, 1539, 1569,  
1577, 1578, 1579, 1914,  
1915, 1923, 1942, 1956,  
2163, 2233, 2311, 2328,  
2334, 2389, 2391, 2395,  
2409, 2418, 2420, 2421,  
2422, 2423, 2442, 2443,  
2444, 2445, 2446, 2448,  
2450, 2506, 2507, 2699,  
2831, 2832, 2833, 3027,  
3084, 3115, 3134 
942, 2029 
cluster30 1149  742, 1975, 2482 
 
 
